Watch · 68/100 · medium confidence

Paylocity Holding Corp (PCTY) — Council Assessment

🟡 WATCH · Score 68/100 · medium confidence

High-quality, near-debt-free HCM SaaS compounder at a genuinely reasonable 14x P/FCF, but decelerating growth and terminal-value-heavy upside keep it a Watch rather than a clean Pass.

As of 2026-06-28. 18 lenses weighed in, 0 abstained. Sources: 6 filings, 15 news, 15 discussion, 1 earnings_call.

360 narrative — news & sentiment digest

PAYLOCITY HOLDING CORP (PCTY) — Investment Briefing

Management Commentary (Q1 FY26 Earnings Call, 2025-11-10)

Strong execution with elevated guidance and long-term targets expanded.

Revenue & Growth:

Q1 recurring + other revenue: 14% YoY growth (standout strength)
Total revenue: $408.2M, +12% YoY
Q1 FY26 guidance raised; FY26 total revenue guided $1.715–1.730B (+8% YoY); recurring revenue $1.605–1.620B (+10%)
CEO Steve attributes momentum to "modern AI-driven platform" and successful July launch of Paylocity for Finance (expanding beyond HCM into CFO/spend management)

Margins & Profitability:

Adjusted gross margin: 75.1% (Q1), up 110 bps YoY
Adjusted EBITDA: $146.4M, 35.9% margin in Q1 (beat guidance by $11.4M); FY26 guided $615–625M (+40 bps leverage at midpoint excluding client fund interest)
Free cash flow margin: targeting 25–30% (long-term, up from prior 20–25%)
G&A at 8.8% of revenue, down 70 bps YoY

Capital Allocation & Cash:

Repurchased 1.2M shares at $172.30/share ($200M) in Q1; $500M cumulative since May 2024 (3M shares); $500M remaining under program
Ended Q1 with $165.2M cash; $81.3M outstanding on credit facility (Airbase acquisition debt, $81.3M paid down in Q1)
Tax benefit of ~$65M expected in FY26 from OBBA R&D deduction changes

Product & AI Strategy:

Next-gen AI Assistant announced at HR Tech (Sept): answers questions, provides real-time data, executes workflows (e.g., "how many vacation days left?" → instant answer + action link)
Usage of AI features doubled YoY; 1.2M+ questions answered by AI Assistant
Paylocity named G2 leader across 10 HCM categories (Fall 2025)
Paylocity for IT in early days: asset/identity management leveraging employee record data; described as "between one larger HCM module and Airbase ARPU" (~$25–30K baseline for Airbase)

Client Metrics:

Strong client retention reported; broker channel >25% of new business (consistent multi-year)
Early Paylocity for Finance traction: "pleased with momentum… both from existing clients and prospects"

Long-Term Targets Updated (elevated vs. Aug 2023):

Revenue: $2B → $3B
Adjusted gross margin: 75–80% → 80%+
S&M spend: 20–25% → 15–20% of revenue (improved efficiency from AI/automation)
G&A: 5–10% → 5–7%
Adjusted EBITDA margin: 35–40% → 40–45%
Free cash flow margin: 20–25% → 25–30%
Stock-based comp: <10% → 5% of revenue

Tone & Candor:

Management confident but measured; emphasizes "early days" on Finance/IT; acknowledges fleet headwinds neutrality (flat headcount assumed for FY26, observed through Oct); ready to "beat and raise" if execution holds. CFO Ryan Glenn noted internal AI productivity gains (engineers using AI coding assistance daily, ops case volumes down, sales automation underway). Discipline evident: margin upside held vs. guided, prioritizing flexibility for growth investments.

Recent Developments

Q1 FY26 results (Nov 2025): Recurring revenue +14%, total revenue +12%; beat EBITDA guidance
Paylocity for Finance launch (July 2025): Expanded platform into CFO office; integrated with HCM for spend management workflows
Paylocity for IT rollout: Early-stage; device/asset management tied to employee records
Next-gen AI Assistant (Sept 2025): Natural-language interface for Q&A and workflow automation across HCM, Finance, IT
Long-term financial targets raised (Nov 2025): $3B revenue, 40–45% EBITDA margin, 25–30% FCF margin
Share repurchases: $200M in Q1; $500M cumulative; program ongoing with $500M authorization remaining
Elevate client conference (Nov 2025): Annual event; management noted "positive YoY momentum" in registration

Bull Narrative

Institutional & Analyst View:

Expanding TAM via Finance & IT: Paylocity for Finance is resonating in early days; management noted willingness to pay on value delivered. IT module taps identity/asset management—higher ARPU potential. Combined, they broaden the addressable market and retention anchor.
AI-driven differentiation & productivity: Next-gen AI Assistant showing strong adoption (1.2M+ questions YoY), driving platform penetration and user simplification. Internal efficiency gains (engineering, ops, sales automation) are translating to margin expansion without sacrificing growth investment—setting up operating leverage.
Margin expansion runway: Long-term guidance lifts gross margin to 80%+, EBITDA margin to 40–45%, and FCF margin to 25–30%. Management demonstrated 110 bps gross-margin leverage in Q1 while investing heavily in R&D; implies room to compound profitability.
Resilient execution in macro stability: Q1 recurring revenue grew 14% despite flat workforce assumptions; broker channel stable >25% of new business; client retention strong. No demand deterioration cited through Oct.
Capital return discipline: $500M repurchased YTD; stock-based comp target cut to 5% of revenue; free cash flow expected to benefit $65M from tax legislation in FY26.

Retail/Forum Sentiment (bullish subset):

"PCTY under $100 is gold loading zone! Look at those financials!" (@AuStocks, May 2026)
"PCTY oversold again!" (@Lucky0209, June 2026)
Anvesti opened long position at $103.72 (ML model score 77.2, June 2026)
Options traders bullish: Nov 2026 $100 calls targeting 53% ROI

Bear Narrative

Skeptical Voices:

AI margin erosion concern: Some traders view AI investments in SaaS as eroding long-term margins rather than expanding them. One contrarian (@JoeB07, April–May 2026) lists PCTY among "AI Losers" with recommendation to protect via puts or sell, citing "AI destroys value." This reflects skepticism that AI will deliver promised efficiency rather than being a cost center.
Guidance conservatism vs. execution risk: Management raised long-term targets sharply (e.g., $2B → $3B revenue) and FY26 guidance, but still has "level of prudence embedded." If macro softens or cross-sell (Finance/IT) adoption lags, beats may plateau.
Multiple compression in software sector: Jefferies lowered PCTY price target to $135 from $150 (May 2026) after Q1 earnings, citing "software group" updates. Even as earnings improve, valuation may face headwinds if rates stay elevated or growth decelerates.
Broker channel concentration: >25% of new business from brokers is strength but also dependency; if broker partnerships shift or consolidation reduces channel vitality, growth could stumble.

Retail Sentiment

Overall: Bullish-to-mixed with pockets of strong conviction.

Majority tone: Optimistic on product innovation (AI, Finance/IT expansion) and financial momentum. Recurring revenue growth (14%) and margin expansion resonate.
Options/technical traders: Bullish on dips; call spreads showing conviction for upside (53% ROI targets on Nov calls at $100 strike).
Dissenters: Small but vocal contrarian camp views AI spend as value-destructive; notes sector-wide software valuation pressure. Limited detail; broad skepticism rather than fundamental critique.
Conviction level: Moderate-to-high among longs; lower among bears (mostly thematic rather than company-specific).

Caveats

"Early days" disclosures: Finance and IT modules launched recently (July 2025, ongoing). No revenue contribution breakout provided; traction claims rely on anecdote ("pleased with momentum") rather than disclosed metrics (pipeline, attach rates, unit economics).
Long-term targets lack phasing: $3B revenue and 40–45% EBITDA margin by when? No timeline disclosed. Implies 3–5+ year runway, but no explicit bridge; credibility hinges on sustained execution across Finance, IT, and core HCM.
Macro assumption: flat headcount & rate guidance. FY26 guidance assumes flat workforce (no hiring) and 25 bps rate cuts in Dec, March, April. If labor market softens faster or rates cut less, guidance may slip.
Interest income on client funds: Q2 guidance includes $27M interest income on ~$3B average client-fund balance (360 bps yield). This is non-operating leverage; if rate cuts accelerate or clients withdraw cash, this tailwind reverses. FY26 assumes ~$110M client-fund interest income; a 50 bps yield cut = ~$15M headwind.
Analyst coverage gaps: Limited third-party data on Finance/IT competitive positioning, win rates vs. Workday/Oracle/SAP, or customer feedback beyond management. Jefferies' target cut (though still Buy-rated) suggests some caution but no deep sell-side thesis on offer.
Stock-based comp trajectory: Despite guidance to cut to 5% of revenue, the company repurchased $200M in Q1 at $172.30/share and has $500M remaining. Continued buybacks at current multiples may cap EPS accretion if revenue growth slows.
Broker channel dependency: >25% of new business from brokers is stable but means 75% is direct. If large enterprise win rates slow or SMB/mid-market growth decelerates (where brokers are strong), the mix could shift unfavorably.

Synthesis: PCTY delivered strong Q1 execution (14% recurring-revenue growth, margin leverage, raised FY26 guidance) and upgraded long-term targets ($3B, 40–45% EBITDA margin) underpinned by AI adoption and Finance/IT expansion. Management tone is confident but disciplined; tone suggests room to beat. However, Finance/IT are early-stage; long-term targets lack a clear roadmap; macro assumptions are conservative (flat headcount, benign rates); and client-fund interest income (~$110M annually) is a non-recurring tailwind. Retail sentiment is bullish; bear case is niche (AI margin erosion, sector valuation pressure). Valuation risk exists if guidance stalls or rates cut less than assumed.

Bull case

Paylocity is a demonstrably high-quality franchise: ROIC ~21.9%, ROE ~20.7% earned with essentially zero leverage (LTD $938K), 27.5% FCF margin, and FCF ($405M) that materially exceeds net income ($227M) every year — a clean earnings signature the forensic short-seller explicitly praised. Switching costs in embedded payroll/compliance workflows are real, gross margins are 75%+ heading to 80%, and capex is under 1% of revenue so growth self-funds. At $106 (down 46% from the $198 high), P/FCF of 14x and P/E of 25x price in near-stagnation; the DCF base case ($255) and even bear case ($192) imply large upside, and Mauboussin's expectations analysis shows even a 4-5% FCF-growth bear case roughly breaks even — asymmetric payoff. Quality and growth lenses (Akre 78, Fisher 82, Smith 78, Mauboussin 76, Munger 74) cluster bullish, and the valuation referee (78) and AI referee (72) both bless it.

Bear case

Growth is decelerating sharply — from ~20% 3-yr CAGR to Q3 FY26 +10.5% and Q4 guided 7-8% — which undercuts the DCF's 12% FCF-growth assumption, and 83% of the DCF's value sits in terminal value, so the headline 140% upside is far softer than it looks. Greenwald's no-growth EPV pegs fair value near $64, ~66% below the current price, meaning you are paying up for unproven Finance/IT modules that management describes as 'early days' with zero disclosed unit economics, attach rates, or win rates against Workday/Oracle/Rippling. ~$110M of client-fund interest income (~7-8% of revenue) is a rate-sensitive non-operating tailwind that reverses on cuts, flattering FCF quality. Buybacks at $172 (now $106) reveal capital-allocation timing errors, insiders are net sellers, and Graham/Schloss flag no margin of safety on any asset or conservative-earnings basis. Rippling's AI-native architecture is an underappreciated 5-10 year structural threat.

Dissent — where the council disagrees

The value bench splits hard from the quality/growth bench. Graham (28) and Schloss (18) Avoid outright — 25x P/E, 5.2x book, no dividend, no asset floor, stock near its 52-week high with a growth-narrative thesis. Greenwald (58) is the most incisive dissenter: on a conservative no-growth EPV (~$64/share) the price is ~66% too high, meaning buyers are explicitly paying for growth in unproven adjacencies. Druckenmiller (52) flags the broken tape — a stock at its 52-week low while management claims acceleration is 'screaming distribution,' preventing high-conviction long sizing. Dalio (52) warns of single-regime dependence on US employment plus rate-sensitive float income. These are not stylistic quibbles: they converge on the same load-bearing risk — the bull case requires sustained 12%+ FCF growth and Finance/IT execution that has not been demonstrated, while growth is visibly rolling over. That tension is why this is a Watch, not a Pass.

Key risks

Revenue growth decelerating from ~20% CAGR to 7-8% guided; if Finance/IT cross-sell fails to re-accelerate, the $3B target and DCF growth assumption both break
DCF is 83% terminal value; modest changes to WACC/terminal growth swing intrinsic value dramatically — headline upside is fragile
~$110M/yr client-fund interest income is rate-sensitive non-operating float income (~$3M per 25bps) that flatters FCF and reverses in a cutting cycle
Finance/IT modules are 'early days' with no disclosed attach rates, win rates, or unit economics vs. Workday/Oracle/SAP and AI-native Rippling
Capital allocation timing errors ($200M buyback at $172 vs. $106 now) plus net insider selling
No margin of safety on conservative EPV/asset basis (~$64 EPV vs $106 price); pays full price for growth

Catalysts

Disclosed Finance/IT revenue contribution, attach rates, or ARPU proving cross-sell traction
Revenue growth re-acceleration above 12% or confirmed gross retention >92%
Continued EBITDA/FCF margin expansion toward the raised 40-45% / 25-30% targets
Further price weakness (<$90) opening a genuine ~9%+ FCF yield and clearer margin of safety
Sustained buybacks executed at current depressed prices (accretive vs. prior $172 tranche)

DCF valuation (finance-expert model)

two-stage DCF, Gordon terminal value, CAPM-weighted WACC.

Intrinsic value: $255.35/share vs price $106.35 → +140% (bear $191.78 · base $255.35 · bull $255.35).

Step	Value
Base free cash flow	$405M
FCF growth (yrs 1-5)	12.0% (revenue CAGR)
WACC (β 0.518)	7.0%
Terminal growth	2.5%
PV of explicit FCF	$2.3B
PV of terminal (residual) value	$11.6B (83% of EV)
Enterprise value	$13.9B
less Net debt	$-162M
= Equity value	$14.1B
/ Shares (55M) = intrinsic/share	$255.35

⚠️ intrinsic value diverges >100% from price — treat as indicative; check FCF normalization (lumpy/one-off cash flows)

Short-sell evaluation

🚫 AVOID SHORTING

This is a poor short despite full-price value multiples and decelerating growth. The forensic short-seller scored it 72 (a pass, meaning clean) precisely because the classic short red flags are absent: FCF materially exceeds net income every year, there is effectively zero debt (no debt-wall or refinancing catalyst), and earnings quality is high. The only real short angles — decelerating growth, rate-sensitive float income, and stretched terminal-value-based upside — are gradual fundamental concerns, not accounting fraud or a solvency catalyst. Against those you face a debt-free balance sheet, $405M of growing FCF, an active $500M buyback, a durable switching-cost moat, a stock already down 46% and sitting at its 52-week low (much of the deceleration already priced), a low 0.52 beta, and the unlimited-downside asymmetry of shorting a quality compounder that most quality lenses rate a buy. The risk/reward is unattractive.

Pros (the short could work)

Full-price multiples (25x P/E, 5.2x P/B) with no asset or conservative-EPV floor (~$64 EPV vs $106 price per Greenwald)
Clear revenue deceleration (20% CAGR to 7-8% guided) undermining the growth premium
~$110M rate-sensitive float income flatters FCF and reverses on rate cuts
DCF upside is 83% terminal value and Finance/IT growth catalysts are unproven — sentiment could de-rate if they disappoint
Broken tape/negative momentum and analyst target cuts (Jefferies $150 to $135) provide near-term downward drift

Cons (what kills the short)

Debt-free balance sheet ($938K LTD), $405M and growing FCF — no solvency or refinancing catalyst to force a repricing
Clean earnings quality: FCF exceeds net income every year, the opposite of a Chanos setup
Durable switching-cost moat, 75%+ gross margins, and 21.9% ROIC make this a quality compounder most lenses rate a long
Already down 46% and at 52-week low — much bad news priced; stock is cheap enough that longs (Akre, Fisher, Smith, valuation referee) see 80-140% upside
Active $500M buyback provides price support and squeeze risk against shorts
Low beta (0.52) and unlimited-downside asymmetry of shorting a profitable, growing franchise

Council scorecard

Lens	School	Stance	Score	Conf
Philip Fisher	growth	🟢 pass	82	high
Chuck Akre	quality	🟢 pass	78	high
Valuation Referee (Damodaran-style)	referee	🟢 pass	78	medium
Terry Smith (Fundsmith)	quality	🟢 pass	78	high
Michael Mauboussin	quality	🟢 pass	76	medium
Charlie Munger	quality	🟢 pass	74	medium
Forensic Short-Seller (Chanos/Einhorn-style)	referee	🟢 pass	72	medium
AI & Disruption Referee (Christensen-style)	referee	🟢 pass	72	medium
Warren Buffett	quality	🟡 watch	62	medium
Joel Greenblatt	value	🟡 watch	58	medium
Bruce Greenwald	value	🟡 watch	58	medium
Peter Lynch	growth	🟡 watch	58	medium
Ray Dalio	risk	🟡 watch	52	medium
Stanley Druckenmiller	risk	🟡 watch	52	medium
Howard Marks	risk	🟡 watch	52	medium
Seth Klarman	value	🟡 watch	48	medium
Benjamin Graham	value	🔴 avoid	28	high
Walter Schloss	value	🔴 avoid	18	high

Member reasoning

Philip Fisher — 🟢 pass · 82/100 · high confidence

Paylocity is a textbook Fisher growth name: sustained double-digit organic revenue growth (3-year CAGR 20.2%), a credible multi-year runway via genuine product expansion (HCM → Finance → IT), disciplined R&D converting into actual product launches and AI adoption, and management that has consistently communicated candidly, raised long-term targets from a position of strength, and reinvested rather than distributed. The company earns high marks on nearly every Fisher criterion. Key concerns are the meaningful revenue deceleration from 20%+ CAGR to guided ~8-10% FY26 growth, early-stage and unquantified Finance/IT modules, and some non-operating tailwinds in FCF that could flatter the picture.

Key points

Organic revenue CAGR of 20.2% over three years (FY2021 $632M → FY2025 $1.47B) driven by volume/client expansion in core HCM, not acquisitions or price hikes — the gold standard under Fisher Point 1.
Genuine product pipeline conversion: Paylocity for Finance (July 2025), Paylocity for IT (2025 rollout), and next-gen AI Assistant (Sept 2025) represent R&D converting into new market-expanding modules — not vaporware. AI Assistant logged 1.2M+ user interactions YoY; G2 leader in 10 HCM categories corroborates product quality via independent scuttlebutt.
Superior and expanding margins: adjusted gross margin 75.1% in Q1 FY26 (+110 bps YoY); operating margin 20.7% on GAAP basis; FCF margin 27.5% on $405M FCF. Long-term EBITDA margin target raised to 40–45% and FCF margin target raised to 25–30% — management demonstrating cost discipline alongside growth investment, not trading off one for the other.
Management candor and long-term orientation are strong: CFO Ryan Glenn provided clear macro assumptions (flat headcount, 25 bps rate cuts), explicitly disclosed interest-income tailwinds and their sensitivity, flagged 'early days' on Finance/IT rather than over-claiming, and raised long-term targets only after demonstrating Q1 beat. This is Fisher-grade disclosure quality.
Capital allocation is shareholder-friendly without being short-termist: $500M cumulative buybacks since May 2024 funded from FCF, SBC target cut to 5% of revenue (a long-term discipline signal), and continued R&D investment — the firm is not sacrificing the franchise for EPS.
Deep sales organization: broker channel >25% of new business (stable multi-year), expanding to Finance/IT cross-sells, with AI automation reducing S&M cost toward a 15–20% of revenue long-term target — evidence of a scaling, productive sales force per Fisher Point 4.
DCF at 7% WACC yields intrinsic value of $255/share vs. $106 current price — 140% upside — with even the bear case at $192. At a 14x price-to-FCF multiple for a business growing FCF at 20%+ historically, the growth is essentially being offered at a significant discount.

Red flags

Revenue growth is decelerating materially: FY2024 was +16.7%, FY2025 +14.8%, and FY2026 guidance implies only ~8-10% total revenue growth (Q3 FY26 actual: $502M, +10.5% YoY). For a Fisher growth stock this deceleration requires close monitoring — Fisher would demand evidence the new Finance/IT modules are genuine re-acceleration catalysts, not just management optimism.
Finance and IT modules are 'early days' with no disclosed revenue contribution, attach rates, or unit economics. Fisher's scuttlebutt method would demand independent corroboration of customer willingness to pay and competitive win rates vs. Workday/Oracle/SAP before assigning full credit — this data is absent from the fact base.
Non-operating interest income on $3B+ client fund balances (~$110M in FY26) inflates FCF and EBITDA; if rate cuts accelerate, this tailwind reverses materially. A 50 bps yield cut = ~$15M headwind. Fisher would be alert to FCF quality risk here.
Insider selling (CFO sold 1,034 shares; SVP sold 70 shares open-market) is a modest negative signal, though CFO sale is under 10b5-1 plan. Not alarming but worth noting alongside deceleration.
52-week high was $197.78; stock is currently at $106.35, down ~46% from highs. While valuation is now attractive, this suggests the market is pricing in sustained deceleration — the burden of proof on management to demonstrate re-acceleration via Finance/IT is high.

Chuck Akre — 🟢 pass · 78/100 · high confidence

Paylocity is a textbook candidate for the three-legged stool framework. First leg (extraordinary business): PCTY earns ROIC of 21.9% and ROE of 20.7% with virtually no financial leverage (long-term debt essentially zero, debt/equity 0.09%), meaning these returns are genuine business economics — not leverage artifacts. FCF margin is 27.5% on $1.47B revenue with minimal capex ($13M on $1.47B revenue — capex/revenue under 1%), confirming the capital-light franchise. Operating margins of 20.7% and rising gross margins (75.1% in Q1 FY26, targeted 80%+) reflect strong pricing power and switching costs inherent in payroll/HCM SaaS. Second leg (management skill and integrity): Capital allocation has been disciplined — $500M in buybacks since May 2024, buybacks executed at ~$172/share (well above current $106), which raises some concern about timing, but the program reflects genuine capital return orientation. Long-term targets have been elevated credibly (EBITDA margin 40-45%, FCF margin 25-30%, SBC targeted at 5% of revenue). CFO-level candor in earnings calls is evident. Third leg (reinvestment runway): This is the most compelling leg. Revenue CAGR of 20.2% over three years; expansion from core payroll/HCM into Finance (Paylocity for Finance, July 2025) and IT modules meaningfully expands TAM. AI adoption driving platform stickiness. Long-term revenue target raised from $2B to $3B with no phasing disclosed — but the vector is clearly positive. The valuation is genuinely attractive: price/FCF of 14.1x on $405M of FCF, P/E of 25x, price/sales of 3.9x, and the DCF at 7% WACC yields an intrinsic value of $255/share — 140% upside even on conservative 12% FCF growth assumptions. Current price at 52-week low ($106.35) represents a significant discount from the $172 buyback price. PEG of 1.24 is reasonable for a 20%+ ROIC compounder. Key risks: (1) buybacks at $172 look overpriced in hindsight vs. current $106, suggesting management may not be optimal capital allocators at the margin; (2) Finance/IT modules are early-stage with no disclosed unit economics; (3) client-fund interest income (~$110M annually) is a rate-sensitive non-operating tailwind that could reverse; (4) growth deceleration is visible — Q3 FY26 revenue only +10.5% YoY vs. prior 14%+ trend. Overall, this is a high-quality compounding franchise at an attractive price with all three stool legs intact, though the reinvestment runway quality will require monitoring as new modules prove out.

Key points

ROIC of 21.9% and ROE of 20.7% with near-zero leverage (LTD <$1M) — genuine business economics not leverage artifacts
FCF of $405M on $1.47B revenue (27.5% FCF margin); capex <1% of revenue confirming capital-light model
Price/FCF of 14.1x and P/E of 25x are attractive for a 20%+ ROIC compounder with multi-year growth runway
DCF intrinsic value ~$255/share vs. $106.35 current price implies substantial margin of safety even under conservative assumptions
Revenue CAGR of 20.2% over 3 years; Finance and IT module expansion meaningfully extends TAM and reinvestment runway
Long-term targets raised: $3B revenue, 40-45% EBITDA margins, 25-30% FCF margin — credible given demonstrated execution
SBC target cut to 5% of revenue; $500M buyback program demonstrates capital return discipline
AI adoption (1.2M+ questions answered, usage doubled YoY) deepening platform moat and user switching costs

Red flags

Buybacks executed at ~$172/share while stock trades at $106 — capital allocation timing error raises modest integrity concern about price discipline
Q3 FY26 revenue growth decelerated to 10.5% YoY from 14% trend — bears watching for further deceleration
Client-fund interest income (~$110M annually) is a rate-sensitive non-operating item that flatters FCF; a meaningful rate cut cycle could reduce reported FCF by $15-30M
Finance and IT modules are early-stage with no disclosed unit economics, win rates, or pipeline data — reinvestment runway expansion unproven
Jefferies lowered price target to $135 from $150 post-Q3 earnings, signaling some analyst caution on near-term trajectory
Stock at 52-week high per data block (conflicting signal — price data shows last close = 52w high at $106.35, likely a data artifact worth flagging)

Valuation Referee (Damodaran-style) — 🟢 pass · 78/100 · medium confidence

PCTY's current price of $106.35 sits at a substantial discount to the DCF's base-case intrinsic value of $255.35 (140% upside), and even the bear case of $191.78 implies 80% upside. While I treat these outputs with appropriate skepticism given the DCF's heavy terminal-value reliance (83% of equity value), a reverse-engineering of implied expectations from the current price reveals a more sobering but still manageable picture. At $106.35 with 55.2M shares, the equity is priced at ~$5.9B market cap. Against FY25 FCF of $405M and ROIC of ~21.9% (well above a 7% WACC), the implied perpetual growth baked into today's price is quite modest — roughly 5-7% long-term FCF growth, which is arguably too pessimistic for a company growing recurring revenue at 14% YoY with expanding margins. The story-to-numbers connection is coherent: revenue CAGR of ~20% over 3 years decelerating toward 8-12% near-term (management guided FY26 recurring rev +10%), FCF margin already at 27.5% and targeted to reach 25-30% long-term, ROIC of 21.9% comfortably above WACC. The key variables for the DCF are defensible: a 7% WACC for a low-beta (0.52), debt-free HCM SaaS company is reasonable though arguably slightly generous; 12% FCF growth for Stage 1 is achievable given Q3'26 showed EPS +26% YoY; terminal growth of 2.5% is at the upper end of prudent but not egregious. The 83% terminal value reliance is the principal concern — it means most of the value depends on Stage 2 stability assumptions that are inherently uncertain. However, even stress-testing WACC to 9% and terminal growth to 2% would dramatically reduce intrinsic value but likely leave it still above $150, suggesting genuine margin of safety. ROIC >> WACC is the critical value-creation confirmation: incremental investment in AI, Finance module, and IT module is generating returns well above cost of capital. The sales-to-capital ratio and near-zero capex ($13M on $1.47B revenue) confirms an asset-light model where growth doesn't require destructive reinvestment. The price-to-FCF of 14x is historically cheap for a SaaS compounder with 20%+ ROIC. Key risks: the terminal value dominance, early-stage Finance/IT modules lacking disclosed unit economics, client-fund interest income (~$110M in FY26) inflating FCF somewhat non-recurringly, and the possibility that growth decelerates faster than modeled if AI disruption or macro headwinds emerge. The 52-week high is $197.78 vs. today's $106.35 — the stock has been cut nearly in half from its high, a stark compression that creates genuine margin of safety if the business thesis holds.

Key points

Reverse-engineered implied growth from $106.35 price is ~5-7% perpetual FCF growth — modest for a 14% recurring-revenue grower with 22% ROIC
ROIC of 21.9% vs. WACC of ~7% confirms growth is value-creating, not value-destructive — the most important Damodaran criterion
Asset-light model (capex $13M vs. $1.47B revenue) validates capital efficiency; FCF conversion is high and rising (FCF margin 27.5% in FY25)
Price-to-FCF of 14x is historically inexpensive for a SaaS compounder with this margin profile and growth trajectory
DCF base case of $255.35 and even bear case of $191.78 imply substantial margin of safety; price doesn't require heroic assumptions to generate returns
FY26 Q3 showed GAAP EPS +26% YoY, recurring revenue +14% — execution is tracking ahead of the modeled 12% FCF growth
Management raised long-term EBITDA margin targets to 40-45% and FCF margin to 25-30% — these are achievable extrapolations of current trajectory, not fantasy
Near-zero long-term debt (D/E 0.0009) means WACC is essentially cost of equity; 7% WACC is defensible for a 0.52-beta business

Red flags

Terminal value is 83% of total equity value — the DCF is highly sensitive to terminal growth and WACC assumptions; any error in these is amplified dramatically
Client-fund interest income (~$110M annually at 360bps on ~$3B float) inflates FCF; a 100bps rate cut reduces FCF by ~$30M, making trailing FCF a slightly optimistic base
Finance and IT modules lack disclosed revenue/ARPU metrics; their contribution to the growth story is narrative, not numerical — management's 'pleased with momentum' is not a number
52-week high of $197.78 vs. $106.35 today suggests significant multiple compression; the DCF used 12% FCF growth sourced from revenue CAGR — if growth is decelerating (FY26 guide ~8-10% total revenue), Stage 1 growth may be too optimistic
Insider sells (CFO Rule 10b5-1, SVP open-market sale) are minor but worth noting; buybacks at $172/share in Q1 vs. current $106 imply prior capital allocation was not value-optimal

Terry Smith (Fundsmith) — 🟢 pass · 78/100 · high confidence

Paylocity is a high-quality HCM/payroll SaaS business that passes the Fundsmith quality screen on most key criteria. ROIC of 21.9% and ROE of 20.7% demonstrate sustained returns well above cost of capital. The business is exceptionally asset-light with capex of only $13M against $405M FCF — a capex-to-revenue ratio of under 1% — meaning growth is essentially self-funding from operating cash. Gross margins are not disclosed explicitly in the fact base but operating margins of 20.7% and FCF margins of 27.5% confirm strong cash conversion; free cash flow of $405M significantly exceeds net income of $227M, which is a hallmark of high-quality accounting (the gap reflects client-fund float and working capital dynamics, but cash conversion is genuine). Revenue has compounded at ~20% CAGR over three years with recurring, subscription-based demand from SMB and mid-market employers — exactly the kind of sticky, repeat-purchase model Smith prizes. Switching costs in payroll/HCM are formidable: migrating payroll is painful, error-prone and compliance-sensitive, so churn is structurally low. The balance sheet is essentially debt-free (long-term debt $938K, per filings) with net cash of ~$162M, satisfying the leverage test emphatically. The DCF suggests significant undervaluation at $106 vs. intrinsic $255 (base case), and even the bear case at $192 implies ~80% upside — a meaningful margin of safety for a quality compounder. The primary Fundsmith concern is the $500M buyback program executed at $172/share average in Q1 FY26 (vs. current $106), suggesting capital was deployed at elevated prices, but the ongoing program at current levels is accretive. Recent earnings show Q3 FY26 GAAP EPS +26% YoY and revenue +10.5% YoY, demonstrating continued execution. Long-term targets ($3B revenue, 40-45% EBITDA margin) are ambitious but grounded in visible platform expansion (Finance, IT modules) and AI-driven productivity. The main risk under the Fundsmith lens is whether the Finance/IT adjacencies represent genuine high-ROCE reinvestment or scope creep that dilutes focus — management describes these as early-stage, so execution risk is real. Valuation at 14x price-to-FCF is genuinely attractive for this quality profile and growth trajectory, well within Smith's 'fair price for outstanding business' framework.

Key points

ROIC 21.9% and ROE 20.7% — sustained returns well above cost of capital across multiple years
FCF $405M vs. net income $227M — strong and genuine cash conversion, asset-light model
Capex only $13M (0.9% of revenue) — self-funding growth with minimal capital intensity
Near-zero debt (LT debt $938K) — balance sheet is a strength, not a risk
20% revenue CAGR over 3 years with recurring HCM/payroll demand — high switching costs and structural stickiness
Price-to-FCF of 14x — genuinely cheap for quality; DCF intrinsic value $255 implies ~140% upside
Operating margin 20.7%, FCF margin 27.5% — durable profitability with margin expansion trajectory to 40-45% EBITDA guided
Platform expanding into Finance and IT adjacencies — incremental TAM with embedded upsell from existing client base

Red flags

Buybacks executed at $172/share average (Q1 FY26) vs. current $106 — capital misallocated at peak prices, though current buyback at lower prices is accretive
Finance and IT modules are early-stage with no disclosed revenue contribution, win rates, or unit economics — execution risk on reinvestment thesis
~$110M annual client-fund interest income is a non-operating tailwind that reverses with rate cuts — obscures true recurring earnings power
Long-term revenue target ($3B) and EBITDA margin (40-45%) lack explicit timeline — credibility relies on sustained cross-sell execution
Jefferies price target cut to $135 (May 2026) signals some analyst concern about near-term growth deceleration despite maintained Buy rating
Stock-based comp historically elevated (targeted to fall to 5% of revenue) — dilution has been a headwind to per-share compounding

Michael Mauboussin — 🟢 pass · 76/100 · medium confidence

Paylocity presents a compelling quality case anchored in a demonstrated ROIC-above-WACC spread, identifiable moat mechanisms, and market-embedded expectations that appear achievable rather than heroic given the current price. ROIC of 21.85% vs. a WACC of ~7% (per the DCF model) implies a spread of roughly 1,485 basis points — wide by any measure. The question is whether that spread is structural or cyclical.

Moat Assessment (Narrow-to-Wide, Trajectory: Strengthening): Three real moat mechanisms are present. First, switching costs: HCM/payroll data is deeply embedded in HR workflows, tax filings, benefits administration, and compliance infrastructure. Ripping out a payroll system means retraining staff, migrating sensitive employee records, re-integrating benefits carriers, and navigating compliance risk — a high-friction, low-frequency decision. This is classic procedural and relational switching cost, and it shows up in the retention numbers (management cites 'strong' retention, though no precise churn figure is disclosed — a gap). Second, supply-side scale economics: with 75%+ adjusted gross margins and FCF margins of 27.5% on $1.47B revenue, fixed-cost leverage is evident. Each incremental client adds revenue with modest marginal cost; R&D and infrastructure are largely sunk. Third, a nascent network/data effect: the AI assistant (1.2M+ queries, usage doubled YoY) and the Finance/IT platform extensions create data loops — more clients mean richer benchmarking, better AI training data, and stickier workflows. This is early and unproven at scale but directionally real. Intangibles (G2 leader in 10 HCM categories) matter less as a moat source than the switching-cost/scale structure.

Expectations Embedded in Price: At $106.35, the market cap is ~$5.7B against FY25 FCF of $405M — a price-to-FCF of 14x. The DCF model at 12% FCF growth and 7% WACC produces an intrinsic value of ~$255/share, implying 140% upside — a gap too large to take at face value without scrutiny. The DCF is highly sensitive to terminal value (83% of equity value), which requires the 12% growth to be sustained over 5 years and terminal growth of 2.5% to be credible. Back-of-envelope: to justify $106 with a 10% WACC and 5% terminal growth (stress scenario), you need FCF growth of only ~6–8%, well below the 3-year revenue CAGR of 20% and even below management's FY26 guided trajectory. This is the key insight: the market appears to be pricing in a deceleration scenario (8–10% growth, compressing multiples) rather than the bull case. P/E of 25x on GAAP earnings and P/FCF of 14x are remarkably modest for a company with 21%+ ROIC and 20%+ revenue CAGR. Even the Jefferies target of $135 (Buy-rated, cut from $150) is 27% above current — analysts are more bullish than the price. The embedded expectations in the current price imply either (a) significant growth deceleration toward GDP-level growth, or (b) multiple compression driven by rate/sector headwinds — both of which require something to go materially wrong.

Probabilistic Distribution:

Bull case (25% weight): Finance and IT modules gain traction, recurring revenue sustains 12–15% growth, EBITDA margins reach 40%+, FCF compounds at management's long-term targets. Intrinsic value $200–255. Significant upside.
Base case (50% weight): Core HCM growth moderates to 8–10%; Finance/IT contribute incrementally but not transformatively; margins expand modestly. FCF grows 8–10% annually. Intrinsic value $140–190. Material upside from current price.
Bear case (25% weight): SMB/mid-market softness, faster rate cuts hammer client-fund interest income (~$110M annually, ~27% of operating income), AI investment proves dilutive, sector re-rating compresses multiples. FCF growth stalls at 4–5%. Intrinsic value $90–120. Limited downside from current levels but de minimis upside.

The asymmetry favors longs: even the bear case barely breaks even from current levels, while the base case offers 30–80% upside. Fat tail risk is macro-driven (rate cuts, employment softness) rather than company-specific.

Capital Allocation: Discipline is evident but not perfect. The $200M buyback in Q1 FY26 was executed at $172.30/share vs. current price of $106 — above intrinsic value if the bear case materializes, a reasonable price if the base/bull case holds. The $500M cumulative buyback at elevated prices is a mild negative. However, R&D investment in AI and Finance/IT appears to be reinvesting at high ROIC (no dilutive M&A beyond Airbase at modest scale), and the SBC target reduction to 5% of revenue signals awareness of dilution discipline. Long-term debt is essentially zero ($938K), giving extreme balance sheet flexibility.

What I Need to Change My Mind (Bearish): Client churn rises meaningfully (no current disclosure); Finance/IT attach rates disappoint over next 2–4 quarters; client-fund interest income drops faster than guided (rate cuts accelerate); AI investment fails to manifest in productivity gains, growing as a cost center instead. The absence of precise retention data is a notable gap.

What I Need to Change My Mind (Even More Bullish): Finance and IT module revenue disclosed and growing 25%+; gross retention above 92% confirmed; EBITDA margin trajectory toward 42%+ in FY27.

Key points

ROIC of 21.85% vs WACC of ~7% implies a ~1,485 bps spread — wide and demonstrably above hurdle; the question is durability
Three concrete moat mechanisms: high switching costs (embedded payroll/HR data, compliance risk of switching), supply-side scale economics (75%+ gross margins, 27.5% FCF margins), and nascent AI/data network effects
Embedded price expectations are conservative: P/FCF of 14x and P/E of 25x price in near-stagnation; even bear-case FCF growth of 4–5% is close to break-even from current levels — asymmetric payoff profile
Revenue CAGR of 20% over 3 years with FCF margin expanding from 18% (FY21) to 27.5% (FY25) — a consistent quality signal that returns on incremental investment are high
Management raised long-term targets ($3B revenue, 40–45% EBITDA, 25–30% FCF margin) with specific mechanism (AI efficiency, Finance/IT ARPU expansion) — process credible though unphased
Near-zero long-term debt ($938K), strong balance sheet; $500M buyback program ongoing — capital allocation disciplined outside Q1 FY26 timing issue (bought at $172 vs $106 current)
Client-fund interest income (~$110M annually) is a real but rate-sensitive tailwind; a 50 bps yield cut = ~$15M headwind, manageable but worth monitoring

Red flags

No precise client retention/churn rate disclosed — the single most important metric for validating switching-cost moat; absence prevents high-conviction scoring
Q1 FY26 buyback executed at $172.30/share ($200M) while stock now trades at $106 — suggests capital was deployed above likely intrinsic value, a capital-allocation misstep
Finance and IT modules are early-stage with no disclosed revenue contribution, attach rates, or win rates vs. Workday/Oracle/SAP — long-term target credibility relies on unverified TAM expansion
Client-fund interest income represents a material (~$110M/yr) but non-operating revenue tailwind that will erode as rates normalize — must be stripped out when evaluating core operating earnings power
Revenue growth deceleration already visible: 20% CAGR (3yr) but Q3 FY26 reported at 10.5% YoY, Q4 FY26 guided 7–8% — the base-rate of mean-reversion in high-growth SaaS is already manifesting; terminal value sensitivity is extreme (83% of DCF value)
Broker channel dependency (>25% new business) is both a strength and a concentration risk if channel economics shift
Sector-wide AI disruption risk: the bearish camp's view that AI erodes HCM software margins rather than expanding them has a non-trivial tail probability — if AI commoditizes payroll processing, switching costs narrow

Charlie Munger — 🟢 pass · 74/100 · medium confidence

Paylocity is a durable, understandable business sitting squarely in a definable circle of competence: cloud-based human capital management (HCM) software sold on recurring subscription to mid-market employers. The unit economics are straightforward — sticky SaaS with high switching costs embedded in payroll and HR workflows. The quality signals are real: ROIC of 21.85%, ROE of 20.68%, FCF margin of 27.5%, operating margin of 20.7%, and a 3-year revenue CAGR of ~20%. Free cash flow of $405M converts cleanly from reported earnings — FCF substantially exceeds net income ($405M vs $227M), which is a hallmark of genuine quality. Debt is essentially zero (long-term debt ~$938K per legacy filing entry, effectively clean balance sheet). Management has been candid about macro assumptions, is executing share repurchases at a measured pace, and has raised long-term targets in a disciplined way. The moat rests on switching costs: once payroll, benefits, compliance, and now Finance/IT are embedded in Paylocity's platform, ripping it out is painful, costly, and risky for the employer. Gross margins of ~75% (guided to 80%+) confirm pricing power. The business can be explained in a paragraph. However, I have three meaningful reservations that prevent a higher score. First, at 14x price-to-FCF and 25x trailing P/E, the price is genuinely fair-to-attractive but NOT obviously cheap — the DCF base case of $255 suggests substantial margin of safety (140% upside), but the terminal value constitutes 83% of enterprise value, making the intrinsic value estimate highly sensitive to assumptions. I treat the DCF as indicative, not gospel. Second, the Finance and IT module expansions are early-stage with no disclosed metrics on attach rates, win rates, or unit economics — management language is promotional ('pleased with momentum') without hard numbers; I penalize opacity. Third, stock-based compensation has historically been elevated; the commitment to cut to 5% of revenue is a target, not a demonstrated fact, and the Q1 FY26 buyback at $172/share (now trading at $106) suggests capital was deployed sub-optimally. Revenue growth is also decelerating — Q3 FY26 revenue grew only 10.5% YoY and Q4 guidance implies 7-8% — down from the 20% CAGR of prior years. Still, at current prices, a high-quality, nearly debt-free compounder with demonstrated FCF generation and real switching-cost moat is not something to walk away from. The inversion test passes: no obvious path to zero — the business is essential infrastructure for its clients, has no leverage, and generates substantial cash. A fair price for a good-to-great business.

Key points

ROIC of 21.85% and ROE of 20.68% — consistently above 15% hurdle; hallmark of a quality compounder
FCF of $405M substantially exceeds net income of $227M — earnings are real and conservatively stated; FCF margin 27.5%
Virtually zero debt (long-term debt negligible) — balance sheet survives any foreseeable downturn
Switching-cost moat is genuine: payroll/HR/compliance workflows are deeply embedded; 75%+ gross margins confirm pricing power
Price-to-FCF of 14x and P/E of 25x at current prices — fair, not expensive, for the quality on offer; DCF suggests large intrinsic value gap
Revenue CAGR 20% over 3 years with expanding margins — incremental reinvestment returns are high
Management raised long-term targets (40-45% EBITDA, 25-30% FCF margin, $3B revenue) with disciplined candor; repurchase program active
Inversion test passes: essential payroll infrastructure, no leverage, strong recurring cash generation — no obvious path to permanent capital impairment

Red flags

Revenue growth decelerating materially: 20% CAGR → 10.5% in Q3 FY26 → guided 7-8% for Q4 FY26; long-term targets lack explicit timeline
Finance and IT module traction disclosed only anecdotally — no attach rates, pipeline metrics, or unit economics; opacity is a yellow flag
Q1 FY26 buyback at $172/share vs. current $106 — $66M of intrinsic value per share erosion on that tranche; capital allocation misstep
Stock-based compensation has been above 10% of revenue historically; 5% target is aspirational, not demonstrated
DCF terminal value = 83% of enterprise value — intrinsic value estimate is highly sensitive to terminal growth and WACC assumptions; treat with humility
Client fund interest income (~$110M annually) is a rate-sensitive non-operating tailwind that will diminish as rates normalize
~$506M gap between current assets and current liabilities is thin (current ratio 1.04) — largely driven by client fund balances which are not the company's own liquidity

Forensic Short-Seller (Chanos/Einhorn-style) — 🟢 pass · 72/100 · medium confidence

Paylocity passes the forensic short-seller screen with a notably clean accounting profile. The core test — earnings vs. cash quality — is actually favorable here: net income of $227M versus operating cash flow of $418M and FCF of $405M means cash generation materially EXCEEDS reported earnings, the opposite of the Chanos red flag. FCF margins have expanded from 18.3% (2021) to 27.5% (2025), and FCF consistently and substantially exceeds net income every year in the history provided. This is a high-quality earnings signature. Debt is essentially nonexistent (long-term debt $938K, debt-to-equity 0.0009), eliminating the refinancing/debt-wall risk entirely. There is no structural financing dependence. Working capital ratios are distorted by the payroll-processing float model (current assets $5.9B vs. current liabilities $5.7B includes ~$3B client fund balances on both sides), which is expected and not a red flag — it's the business model. ROIC of 21.8% and ROE of 20.7% are genuine. The primary forensic concerns are: (1) SBC/buyback treadmill — $200M repurchased at $172.30/share in Q1 FY26 with only ~55M shares outstanding; need to verify if share count is actually declining or buybacks merely offset SBC dilution — fact base doesn't give granular share count history to confirm; (2) ~$110M annual client-fund interest income embedded in operating results is effectively float income dependent on rate environment and could be classified as non-operating — this inflates apparent FCF quality somewhat; (3) insider selling: CFO sold 1,034 shares under Rule 10b5-1 (pre-set, less alarming) and SVP sold 70 shares open-market (de minimis) — not a clustering red flag; (4) growth is decelerating — Q3 FY26 revenue up 10.5% YoY vs. prior 14% recurring growth, and Q4 guidance implies 7-8% — this is a real fundamental concern but not an accounting fraud signal; (5) heavy reliance on non-GAAP EBITDA metrics (GAAP operating margin 20.7% vs. guided EBITDA margin ~37%) — SBC and D&A are large add-backs, but GAAP earnings are still positive and growing, limiting the manipulation risk. The kill question for a short thesis would be: does share count actually shrink despite $500M in buybacks (testing SBC offset), and does client-fund interest income mask deteriorating core HCM unit economics as rate cuts compress that tailwind? Neither of these rises to a compelling short catalyst given the fundamental cash quality. This stock fails to trigger short-seller conviction — hence a pass (not a buy recommendation, but the forensic tests come back clean).

Key points

FCF ($405M) materially exceeds net income ($227M) every year 2021-2025 — earnings quality is high, the opposite of core Chanos red flag
Effectively zero debt (long-term debt $938K) eliminates refinancing/debt-wall risk entirely
Client-fund float (~$3B balance, ~$110M interest income) is real but disclosed and rate-sensitive — a tailwind masking slight core FCF inflation, not fraud
Insider selling is pre-set Rule 10b5-1 (CFO 1,034 shares) and de minimis open-market (SVP 70 shares) — no clustering red flag
Revenue growth decelerating (14% recurring Q1 FY26 → 10.5% Q3 → 7-8% Q4 guided) is a fundamental concern but not an accounting signal
Non-GAAP EBITDA diverges from GAAP (guided ~37% vs. 20.7% GAAP operating margin) due to SBC and D&A, but GAAP earnings are genuine and growing
Share count and SBC offset question unresolved — $500M buybacks at high prices could be treadmill if SBC is large; fact base lacks granular quarterly share-count history

Red flags

Client-fund interest income (~$110M/yr) embedded in operating results is rate-dependent float income — a non-recurring tailwind that flatters FCF; 50bps rate cut = ~$15M headwind per mgmt own disclosure
Buyback math suspect: $200M repurchased at $172.30/share in Q1 FY26 when current price is $106.35 — significant capital destruction on repurchases done near 52-week high area; SBC offset needs verification
Revenue growth deceleration from 20%+ CAGR to 7-8% guided Q4 FY26 is sharp; if Finance/IT cross-sell fails to ramp, the $3B revenue long-term target loses credibility and multiple compresses
Non-GAAP EBITDA margin (37%+) vs. GAAP operating margin (20.7%) implies ~$250M+ annual SBC/D&A add-backs — SBC as share of adjusted profit is material and needs monitoring
Fact base lacks granular DSO, unbilled receivables, or capitalized software cost detail from filing excerpts — cannot fully test receivables-vs-revenue or capitalized cost aggressiveness from available data

AI & Disruption Referee (Christensen-style) — 🟢 pass · 72/100 · medium confidence

Paylocity sits in a genuinely interesting middle position in the Christensen disruption framework. Its core job-to-be-done is running payroll, benefits administration, time/attendance, and increasingly broader HCM workflows for mid-market employers (roughly 20–1,000 employees). Let me stress-test each disruption axis carefully.

The obsolescence question: Can AI do Paylocity's job cheaper and good-enough without Paylocity? The specific jobs are: (1) tax-compliant payroll calculation and filing across 50-state jurisdiction complexity, (2) benefits enrollment/administration and carrier connectivity, (3) ACA/COBRA/FMLA compliance workflows, (4) time/attendance data aggregation, (5) HR recordkeeping and reporting. A bare LLM cannot do these — they require real-time tax table maintenance, carrier EDI connections, government filing infrastructure, and legal compliance liability acceptance. These are not knowledge-work tasks a model replaces; they are system-of-record infrastructure with genuine switching costs. However, the adjacent layer — HR analytics, employee Q&A, workforce planning — IS the kind of knowledge work LLMs commoditize. This is where Paylocity is most exposed on the demand side.

Intermediary/disintermediation test: Paylocity is NOT a pure matching intermediary. It does not sit between two parties taking a routing fee. Its value is the compliance infrastructure, the employer-of-record connectivity, and the workflow embed. The payroll engine and tax filing network are genuine scarce infrastructure — not an optimization function a model can replicate without regulatory, carrier, and government relationships. However, the float income (~$110M annually from ~$3B client funds) IS a quasi-financial toll that compresses if rates fall or if fintechs capture the float.

Moat under AI: The proprietary data Paylocity holds — employee records, payroll histories, benefits utilization, workforce patterns across thousands of mid-market employers — is genuinely hard for a foundation model plus customer-owned data to replicate. The CUSTOMER does not own this data in usable form without Paylocity. The benchmarking and cross-client analytics are a compounding data asset. However, Workday and ADP have larger datasets and hyperscaler partnerships; Microsoft (Dynamics + Copilot), SAP (SuccessFactors + Joule), and Oracle (HCM + AI) have both the HCM footprint and AI infrastructure. These are existential competitive threats at the enterprise level — less so in Paylocity's 20-1,000 employee sweet spot where hyperscalers under-serve.

Tailwind vs. threat on cost side: Paylocity is credibly using AI to LOWER ITS OWN COSTS — the earnings narrative describes engineering productivity (AI coding assistance), ops automation (case volumes down), sales automation, and the AI Assistant handling 1.2M+ employee questions that previously required HR staff time. This is a genuine cost-side tailwind. The long-term EBITDA margin target lift (35-40% → 40-45%) is plausibly AI-driven. S&M target reduction (20-25% → 15-20% of revenue) reflects AI-assisted sales efficiency. These are credible, not marketing veneer.

Threat on demand side: The more serious concern is whether customers eventually self-serve more functions using AI, reducing seat count or reducing cross-sell attachment. The 'Paylocity for Finance' expansion into spend management competes with Brex, Ramp, and others who are AI-native and well-funded. The 'Paylocity for IT' module competes with Rippling, which explicitly pitches a unified HR/IT/Finance platform as an AI-native architecture. Rippling is the most credible AI-native disruptor — it was architected from the start as a connected graph of employee data across HR, IT, and Finance, which Paylocity is now trying to replicate organically.

Hyperscaler capture risk: Microsoft/Copilot + Dynamics 365 HR is the most credible platform threat, but it targets enterprise (>500 employees) not Paylocity's core mid-market. Google Workspace + AI has not made meaningful HCM inroads. The risk is real but concentrated at the upper end of Paylocity's market, not its core base.

Management's honesty: The Q1 FY26 transcript shows genuine engagement — management cites AI productivity gains in engineering, ops case volume reduction, and sales automation, and describes the AI Assistant as both a retention tool and a margin driver. They acknowledge reliance on client-fund interest income and explicitly model rate sensitivity. This is not denial; it is a reasonably honest engagement with both the tailwind and the risk. However, there is no explicit acknowledgment that Rippling or AI-native HCM platforms represent a structural competitive threat — the framing is purely 'we are building AI features,' not 'here is why our architecture wins against AI-native competitors.'

Falsifiable call: Evidence that AI IS displacing Paylocity over 2-4 years: (1) Rippling or other AI-native platforms take measurable share in the 50-500 employee segment; (2) Paylocity's net revenue retention or client retention metrics deteriorate; (3) ARPU stagnates despite Finance/IT cross-sell; (4) gross margin expansion stalls as AI competitors undercut on price. Evidence that AI STRENGTHENS Paylocity: (1) Finance/IT cross-sell drives ARPU above $30K+ for mid-market clients; (2) AI Assistant reduces HR support costs visibly in client surveys; (3) EBITDA margin converges toward 40%+ on schedule; (4) Rippling fails to scale beyond SMB or raises prices. Current evidence is mixed but leans slightly positive — genuine AI-driven cost efficiency, a unique compliance infrastructure moat, and a data asset competitors cannot easily replicate. The risk is real but not acute on a 3-5 year horizon; it sharpens at 5-10 years if AI-native architectures mature.

Net assessment: Paylocity is not a melting ice cube — its compliance infrastructure, multi-state tax filing, and carrier connectivity are genuine non-AI-replicable infrastructure. AI is more tailwind than threat on a 3-5 year view. The 5-10 year risk from AI-native competitors (Rippling primarily) is real and underappreciated. Score reflects a modest-but-genuine moat with a credible AI-tailwind story and a non-trivial disruption risk that justifies a 'pass' with eyes open rather than a high-conviction endorsement.

Key points

Core payroll/compliance infrastructure (multi-state tax filing, carrier EDI, ACA/COBRA workflows) is genuine non-AI-replicable scarce infrastructure — not a matching intermediary or knowledge-work layer that LLMs commoditize
AI is a credible COST-SIDE TAILWIND: AI coding assistance, ops automation (case volume reduction), AI Assistant (1.2M+ Q&A answered), and sales automation are driving long-term EBITDA margin expansion from 35-40% to 40-45% target — management shows genuine internal productivity gains, not marketing veneer
Cross-client employee data (payroll, benefits, workforce patterns across thousands of mid-market employers) is a proprietary dataset customers cannot reconstruct without Paylocity — a compounding data asset, not a moat AI immediately erodes
'Paylocity for Finance' and 'Paylocity for IT' expansions are both the correct strategic response to an AI-native architecture threat AND the right way to raise switching costs — embedding deeper into the employee data graph reduces disintermediation risk
Management engagement with AI is substantive: specific metrics cited (1.2M AI Q&A, ops case volume down, engineering daily AI usage) and long-term targets explicitly incorporate AI-driven efficiency — not a superficial 'AI feature' narrative

Red flags

Rippling is the most credible AI-native disruptor — architected from inception as a connected HR/IT/Finance graph; Paylocity is retrofitting this architecture organically, which is harder and slower; no explicit competitive acknowledgment from management
Finance/IT modules are early-stage and compete with well-funded AI-native fintechs (Brex, Ramp for Finance; Okta, Jamf for IT) that have architectural advantages Paylocity must overcome
Client-fund float income (~$110M annually, ~7-8% of FY26 revenue) is a rate-sensitive quasi-financial toll — if rates decline sharply or fintechs capture the float structure, this tailwind reverses and the earnings quality narrative weakens
On a 5-10 year horizon, if generative AI dramatically reduces the HR compliance complexity that makes Paylocity's infrastructure sticky (e.g., AI-native compliance engines commoditize multi-state tax filing), the core moat narrows materially — this risk is not yet acute but deserves monitoring
Revenue growth deceleration (from ~20% CAGR to guided ~7-8% FY26 Q4) suggests mid-market penetration is maturing and Finance/IT cross-sell must carry incremental growth — if those modules lag, AI-native competitors fill the gap

Warren Buffett — 🟡 watch · 62/100 · medium confidence

Paylocity is an established, profitable HCM/payroll SaaS business with real switching costs, consistently rising margins, and strong free cash flow conversion — all hallmarks I look for. The economics are understandable: employers are sticky once payroll and HR processes are embedded in a vendor's platform; the cost of switching is high (data migration, retraining, compliance risk), creating genuine switching-cost moat similar to what I've admired in businesses like Moody's or American Express. The numbers support this reading: ROE of 20.7%, ROIC of 21.9%, FCF margin of 27.5%, operating margin over 20%, and revenue that has compounded at ~20% over three years — all without meaningful debt (long-term debt essentially zero, D/E of 0.0009). Owner earnings are real: operating cash flow of $418M against capex of only $13M tells me this is not a capital-intensive treadmill. The business funds itself and generates enormous surplus cash. These are wonderful economics. However, I have meaningful reservations that keep me from a full 'pass.' First, valuation: at 14x price-to-FCF and 25x P/E, the stock looks optically cheap relative to the DCF ($255 intrinsic per share vs. $106 market price), and the 52-week high was $197 — the stock has been cut roughly in half. That gap is intriguing. But I must be careful: the DCF assumes 12% FCF growth for 5 years with an 83% terminal value weight — that terminal value dominates and is sensitive to assumptions. If growth decelerates to, say, 7-8% (plausible given the Q3 FY26 revenue growth of 10.5% and Q4 guidance of 7-8%), the intrinsic value compresses meaningfully. Second, the growth deceleration itself is a concern. Revenue grew 14.8% in FY24, 14.8% in FY25, but guidance for FY26 implies roughly 8% total revenue growth — a significant step-down. Q3 FY26 showed 10.5% revenue growth with Q4 guided at 7-8%. This is a maturing growth trajectory, not an accelerating one. Third, the Finance and IT module expansion is genuinely promising but unproven — 'early days' with no disclosed unit economics, win rates, or attach rates. I don't invest in stories; I invest in demonstrated, repeatable earnings power. Management's long-term $3B revenue and 40-45% EBITDA margin targets lack a timeline and a bridge. That is exactly the kind of speculative projection I discount heavily. Fourth, ~$110M annually in client-fund interest income is a non-operating tailwind I'd normalize away — if rates fall, this evaporates. Fifth, insider sales (CFO selling 1,034 shares, SVP selling 70 shares) are small but worth noting. On capital allocation: the $200M share repurchase at $172/share in Q1 FY26, when the stock was significantly higher than today, is not rational capital allocation from a margin-of-safety standpoint — they bought back stock at a price well above current levels. Overall, this is a high-quality business at a potentially fair-to-cheap price, but growth deceleration, early-stage platform bets, and some capital allocation missteps give me pause. I'd want to see the Finance/IT modules contribute measurably to revenue, growth re-accelerate above 12%, and perhaps another year of margin delivery before moving to 'pass.'

Key points

Switching-cost moat is real: payroll/HR platform deeply embedded in client operations; high cost of migration creates sticky recurring revenue
Near-pristine balance sheet: long-term debt essentially zero ($938K), $162M cash, entirely self-funded through operations
Exceptional owner earnings quality: $418M operating cash flow against only $13M capex = $405M FCF; FCF margin 27.5%, improving over 5 years
ROE 20.7% and ROIC 21.9% sustained without leverage — exactly the capital-light, high-return profile I seek
Revenue compounded 20% over 3 years; however, FY26 guidance implies ~8% growth — meaningful deceleration that must be monitored
DCF suggests $255 intrinsic value vs. $106 market price — but 83% terminal value weight makes this highly assumption-sensitive
P/FCF of 14x is the most compelling valuation metric; at normalized FCF of $405M on a $5.7B market cap, the earnings yield is attractive if growth doesn't collapse
Long-term margin targets (40-45% EBITDA, 80%+ gross margin) are credible directionally but lack timeline or phased roadmap

Red flags

Revenue growth decelerating sharply: from ~20% CAGR to 7-8% guided for Q4 FY26 — raises concern about market saturation in core SMB/mid-market HCM
Finance and IT module expansion is entirely unproven — no disclosed revenue contribution, attach rates, or competitive win rates vs. Workday/Oracle/SAP
~$110M annually in client-fund interest income (~7.5% of FY25 revenue) is rate-sensitive non-operating income that could reverse quickly with rate cuts
Repurchased $200M of stock at $172.30/share in Q1 FY26 — well above intrinsic or current price; raises capital allocation discipline question
Long-term targets ($3B revenue, 40-45% EBITDA) lack phasing or timeline — management credibility depends on execution not yet demonstrated for Finance/IT
51-week price decline from $197.78 to $106.35 (46% drawdown) suggests market is pricing in meaningful growth deceleration — not obviously a mispricing
Terminal value dominates DCF (83%) — small changes in terminal growth rate or WACC produce large intrinsic value swings; margin of safety is less certain than headline upside implies

Joel Greenblatt — 🟡 watch · 58/100 · medium confidence

Paylocity is a genuine operating business with measurable EBIT and invested capital, so the Magic Formula framework applies. Working through the two axes: On ROIC, PCTY looks excellent — EBIT of $304M on a tangible capital base that is essentially working capital plus minimal fixed assets (capex of only $13M, net fixed assets are negligible given the asset-light SaaS model; net working capital is distorted by client fund float but the core operating working capital excluding those floated client balances is minimal). ROIC by the reported metric is 21.85%, and by a tighter Greenblatt-style EBIT/(NWC+net fixed assets) calculation, the return is very high — this is a capital-light, recurring-revenue franchise with real operating leverage. On earnings yield, the picture is less compelling. EV = market cap ($5.69B) + long-term debt (essentially nil, $938K) + minority interest (none apparent) - excess cash ($162M) ≈ $5.53B. EBIT = $304M. Earnings yield = $304M / $5.53B ≈ 5.5%. That is not cheap by Greenblatt standards — a Magic Formula screen typically looks for earnings yields north of 8-10% in the top decile. So PCTY scores very well on quality (high ROIC) but only modestly on price (5.5% EBIT/EV). The DCF intrinsic value of $255 vs. current price of $106 is compelling and suggests meaningful undervaluation if the 12% FCF growth assumption holds, but Greenblatt's formula cares about current-year EBIT yield, not terminal-value-heavy DCF arithmetic. Revenue growth is slowing (Q3 FY26 at +10.5% YoY vs. 20% 3-year CAGR), which pressures the forward EBIT yield improvement timeline. There is no special-situation catalyst — this is a straightforward compounder, not a spinoff, restructuring, or recapitalization. The Magic Formula gives a mixed verdict: top-quartile quality, middle-tier cheapness. Watch rather than pass.

Key points

EBIT/EV earnings yield of ~5.5% ($304M EBIT / ~$5.53B EV) is below the Greenblatt buy threshold of 8-10% — price is not yet cheap on an enterprise basis
ROIC of ~22% (reported) is excellent; asset-light SaaS model with minimal tangible capital employed scores top-decile on the quality axis
FCF conversion is outstanding: $405M FCF on $304M EBIT (FCF > EBIT due to favorable working capital from client fund float and SBC), suggesting real, cash-generative economics
Revenue growth decelerating to ~10% in recent quarters from 20% CAGR — limits near-term EBIT yield improvement and increases execution risk on the DCF terminal value
No special-situation catalyst present; buyback program ($500M remaining) provides modest support but not a Greenblatt-style forced-seller/structural mispricing event
DCF intrinsic value of $255 (140% upside) is intriguing but heavily terminal-value dependent (83% residual) — requires sustained 12% FCF growth to 2030+, which is unproven at decelerating current growth rates

Red flags

Earnings yield of 5.5% EBIT/EV places PCTY squarely in the 'quality but not cheap' quadrant — Magic Formula demands both axes
Current price is at 52-week high ($106.35 = 52W high per data), suggesting the market has already re-rated the stock upward, reducing margin of safety
Revenue growth deceleration (20% 3Y CAGR → ~10% recent) risks compressing future EBIT if operating leverage stalls on slower top-line
Client fund interest income (~$110M annually) inflates reported FCF; this is rate-sensitive and non-recurring — normalized EBIT yield is somewhat overstated by this tailwind
CFO and SVP insider sales (10b5-1 plan and open-market) are minor but directionally not aligned with 'insider buying into undervaluation' signal Greenblatt favors in special situations
Significant SBC (~$200M+ buybacks at $172/share in Q1 FY26 partially offsetting dilution) masks true per-share earnings power growth

Bruce Greenwald — 🟡 watch · 58/100 · medium confidence

Paylocity is a genuine operating business with a multi-year earnings history, making EPV analysis fully applicable. The key question is whether EPV supports the current price without relying on speculative growth. Normalized operating income (FY2025 GAAP) is $304M on $1.47B revenue — a 20.7% operating margin. Adjusting for modest excess D&A over maintenance capex (capex is only $13M vs. ~$50-70M true maintenance estimate for a software business of this scale, suggesting reported FCF may be slightly overstated vs. true distributable earnings, though the delta is modest), I normalize NOPAT at roughly $240-260M (tax-affecting the $304M operating income at ~22% effective rate = ~$237M). At WACC of 7% (per the DCF), EPV = ~$237M / 0.07 = ~$3.39B enterprise value. With net cash of ~$162M, equity EPV ≈ $3.55B, or roughly $64/share on ~55.2M shares. The current price of $106.35 represents a ~66% premium to this no-growth EPV estimate. This gap is only justified if growth is protected by durable barriers to entry — which is the crux of the moat question. On the moat, Paylocity does exhibit real barriers: (1) customer captivity is strong — HCM/payroll systems are deeply embedded in client workflows, compliance processes, and employee data; switching costs are high and churn is demonstrably low; (2) economies of scale within the mid-market SMB niche — their platform cost structure benefits from spreading R&D/infra across a large client base; (3) network/data advantages from processing payroll for thousands of employers create proprietary benchmarking and AI-training advantages. These barriers are real but not impregnable — Workday, ADP, Paychex, and Paycom all compete hard in adjacent segments. The EPV-to-reproduction cost gap suggests a genuine but moderate franchise: rebuilding Paylocity's sales force, compliance engine, client integrations, and brand in the mid-market would cost well above $3.5B, meaning EPV > reproduction cost — a positive moat signal. However, the market price at $106.35 ($5.7B market cap) prices in substantial growth beyond current earnings power. The two-stage DCF intrinsic value of $255/share (140% upside) is deeply dependent on a terminal value representing 83% of enterprise value — exactly the long-horizon DCF trap I distrust. Even if we accept 12% FCF growth for 5 years, the current price already embeds optimistic execution on Finance/IT modules that are explicitly 'early days' with no disclosed unit economics. The PEG of 1.24 and P/FCF of 14x are not expensive by growth-stock standards, but my EPV framework does not reward growth unless it is demonstrably moat-protected and the price is at or below EPV. Here the price is ~66% above EPV, requiring the franchise to sustain above-WACC returns on incremental investment in new markets (Finance, IT) where barriers are less proven. One notable positive: the balance sheet is essentially debt-free (long-term debt $938K) with $162M cash and $405M FCF — financial strength is not a concern. ROIC of 21.9% and ROE of 20.7% are well above WACC, consistent with a moated franchise. But at $106 vs. EPV of ~$64, there is no margin of safety on the conservative Greenwald basis. The stock would be attractive at or below EPV (~$64), interesting in the $64-$85 range with franchise premium, but at $106 the price requires trusting growth in new, unproven segments — which is exactly the speculative bet I am trained to avoid.

Key points

EPV estimated at ~$64/share (NOPAT ~$237M / WACC 7%); current price of $106.35 is ~66% above no-growth EPV — no margin of safety on a conservative basis
Real moat indicators present: high switching costs in payroll/HCM (deeply embedded workflows, compliance dependencies), scale advantages in mid-market niche, and data/AI advantages from large employer base
EPV likely exceeds asset reproduction cost, confirming a genuine franchise — but market price requires substantial growth value on top of franchise value
Revenue CAGR of ~20% (3yr) and FCF margin of 27.5% demonstrate strong current earnings power; the business is not distressed or value-destroying
$405M FCF, near-zero debt ($938K LTD), and 21.9% ROIC confirm capital efficiency and financial health
New Finance and IT modules are explicitly 'early days' with no disclosed attach rates, win rates, or unit economics — growth assumptions here are speculative
DCF intrinsic value of $255/share relies 83% on terminal value — the exact long-horizon speculation I discount; treat as optimistic ceiling, not anchor
PEG of 1.24 and P/FCF of 14x are reasonable for a quality compounder but not cheap on an EPV basis

Red flags

Price ~66% above EPV; gap requires sustained above-WACC returns on unproven Finance/IT growth — paying for speculative growth outside the core proven franchise
DCF terminal value = 83% of enterprise value — deeply dependent on long-horizon assumptions where errors compound; not a reliable anchor
Finance and IT module expansion carries competitive risk from entrenched players (Workday, Oracle, SAP) with far larger installed bases in those domains — barriers to entry in these adjacencies are less proven than in core HCM
Jefferies price target cut to $135 from $150 (May 2026) post-earnings despite Buy rating — suggests growth-rate deceleration concerns even among sell-side bulls
Revenue growth decelerating: Q3 FY26 revenue +10.5% YoY vs. 14% recurring in Q1 — execution on guidance requires Finance/IT to re-accelerate growth
Client fund interest income (~$110M/year) inflates FCF; this is rate-sensitive non-operating income that could reverse 15-20% of free cash flow if rates cut faster than assumed — overstates durable earnings power
Insider selling (CFO 10b5-1 plan, SVP open-market sale) at current price levels — weak signal but directionally negative

Peter Lynch — 🟡 watch · 58/100 · medium confidence

Paylocity is a stalwart-to-fast-grower HCM/payroll SaaS business I can explain in one sentence: it sells cloud-based HR and payroll software to mid-market employers and earns recurring subscription revenue that compounds as clients add modules and employees. That's an understandable roll-out story. The problem from my standpoint is the PEG. The reported PEG is 1.24 — above my 1.0 threshold. Revenue CAGR is 20% over 3 years, but revenue growth is decelerating: FY2023 ~30% → FY2024 ~17% → FY2025 ~15% → Q3 FY2026 guidance implies ~10% for the near term. EPS growth in Q3 FY26 was 26% YoY, which is encouraging, but if I anchor to the more relevant forward growth rate of 10-12% (where guidance points), the P/E of 25x becomes a PEG of roughly 2.0-2.5 — that's expensive by my standard. The balance sheet is genuinely excellent: near-zero long-term debt ($938K), ROIC of 21.9%, FCF margin of 27.5%, and $405M of free cash flow. I love the internal funding of growth, the buyback discipline, and the margin trajectory. The AI platform and Finance/IT expansion are a believable roll-out story. But I'm wary of the 'early days' caveat management keeps repeating for Finance and IT — no revenue contribution breakout means I'm buying hope, not disclosed unit economics. Insider activity is modestly negative (CFO sold 1,034 shares, SVP sold 70 shares — small amounts under 10b5-1 plans, not alarming but not buying either). The stock is sitting exactly at its 52-week high of $106.35 — no neglected-stock discount here, and it's well-covered by sell-side. Jefferies still Buy-rated but cut target to $135 from $150. The DCF at $255 base implies massive upside, but 83% of that value is terminal — I'm skeptical of any model where the terminal value drives the whole thesis. Bottom line: excellent business with a durable model, strong balance sheet, and expanding margins, but the PEG is stretched relative to current growth rates, deceleration from 20% to ~10% revenue growth puts this squarely in stalwart territory where I'd buy on dips to 10-15x earnings, not 25x. I'd watch for a better entry or confirmation that Finance/IT actually moves the needle on growth re-acceleration.

Key points

HCM SaaS roll-out story is easily explainable: mid-market payroll + HR cloud platform with module expansion as the growth engine
Balance sheet is pristine: $938K long-term debt, 21.9% ROIC, 27.5% FCF margin — the company funds itself and returns cash via $500M buyback program
Revenue CAGR 20% over 3 years but decelerating: ~30% in FY23 → ~10% in near-term guidance; this matters for PEG calculation
Reported PEG of 1.24 is above my 1.0 threshold; on forward growth of 10-12% the PEG expands to ~2.0-2.5 — not a bargain
AI Assistant adoption (1.2M+ questions YoY) and Finance/IT expansion are believable catalysts for growth re-acceleration, but no disclosed unit economics or revenue breakout yet
Operating margins expanding: 20.7% operating margin, adjusted EBITDA guided $638-642M for FY26 — real profitability, not a concept stock
Long-term targets ($3B revenue, 40-45% EBITDA margin) are ambitious but lack timeline — credibility hinges on Finance/IT conversion

Red flags

Revenue growth deceleration from 30% to ~10% is the central concern — fast grower valuation requires fast grower growth
PEG above 1.0 at reported 1.24, and potentially 2.0+ if forward growth rates of 10-12% persist — classic overpayment risk for a maturing grower
Stock trading at 52-week high with no neglected-stock discount; well-covered by sell-side — no edge from underfollowed story
Finance and IT modules are 'early days' with no revenue contribution disclosed — management's own language signals execution risk on the growth catalyst
Client fund interest income (~$110M annually) is a non-operating tailwind that masks true operating FCF growth — if rates cut accelerates, this reverses
Minor insider selling (CFO, SVP) under 10b5-1 plans — not alarming but zero insider buying signal

Ray Dalio — 🟡 watch · 52/100 · medium confidence

Paylocity is a high-quality, balance-sheet-light HCM SaaS compounder with genuinely low financial leverage (net cash, essentially zero long-term debt, $405M FCF) and sticky, subscription-based revenue that provides some cross-regime durability. However, through the Dalio risk lens, PCTY is meaningfully single-regime dependent — it is structurally a 'falling rates + rising growth + low inflation + tight labor market' story. Its SMB/mid-market customer base is highly sensitive to employment levels and credit availability, both of which deteriorate in stagflation or a deflationary deleveraging. The ~$110M/year in client-fund interest income (earned on ~$3B of float held between payroll cycles) is an explicit rate-sensitivity lever that REVERSES in a falling-rate regime. Client headcount growth assumptions embedded in revenue are pro-cyclical. On the bull side: balance sheet is nearly pristine (LTD of $938K, net cash position), FCF is self-funding with no access to capital markets required, low beta (0.52) provides some equity-book diversification, and pricing power exists via mission-critical switching costs. The DCF at $255 intrinsic vs. $106 current price implies large margin of safety on a going-concern basis, but a regime-stress test (stagflation: lower employment, higher costs, client attrition from SMB failures) compresses near-term FCF meaningfully. Geographic concentration is 100% domestic US — zero FX or global diversification. The valuation at 14x price-to-FCF is attractive by SaaS standards but still embeds 12% FCF growth that requires a labor-market-friendly macro backdrop. Not a regime-robust holding per Dalio's four-box framework, but the balance sheet is strong enough and the valuation discount deep enough to avoid outright avoidance.

Key points

Near-pristine balance sheet: LTD of only $938K, net cash ~$162M, no meaningful refinancing risk or maturity wall — passes the 'survive without capital markets access' test
FCF is large ($405M, 27.5% margin) and recurring subscription revenue from mission-critical payroll/HCM creates base-level resilience even in moderate downturns
~$110M annual client-fund interest income is a rate-cycle lever: rises in higher-rate regime but reverses sharply on rate cuts, making total earnings explicitly rate-sensitive in BOTH directions
Low beta (0.52) vs. broad equity provides genuine diversification value within a typical equity book — correlated to employment/labor cycles but not to industrial capex or housing cycles
DCF intrinsic value $255 vs. $106 price implies ~140% upside — even stress-casing to bear scenario ($191) provides a 80% cushion; margin of safety is substantial
Revenue CAGR of 20% over 3 years demonstrates platform is gaining share; AI adoption (1.2M+ queries, doubled YoY) and Finance/IT module expansions are early-but-real TAM extenders
Regime robustness partial credit: payroll processing is legally non-discretionary for SMBs — employers must run payroll even in recessions, providing floor-level demand durability

Red flags

Single-regime dependence is the primary structural concern: revenue growth is tightly correlated to US employment levels and SMB/mid-market hiring; a deep labor market contraction (stagflation or deflationary bust) would directly compress per-client revenue via lower headcount (PEPM pricing model)
Client-fund interest income ($110M guided FY26) is a non-operating tailwind that reverses in a rate-cutting cycle — management explicitly flags 25 bps sensitivity of ~$3M; 200 bps of cuts = ~$24M headwind to bottom line with NO operational offset
100% US domestic revenue — zero geographic diversification, full exposure to dollar-centric macro regime, no hedge against a weaker USD or US-specific credit/fiscal event
Pro-cyclical demand risk: SMB/mid-market customers are disproportionately impacted in credit contractions; customer attrition risk rises if small businesses fail or freeze headcount growth, compressing Paylocity's revenue without a corresponding fast cost reduction
Share buybacks at $172.30/share ($200M in Q1 FY26) when current price is $106 represent ~38% capital destruction ex-post — signals capital allocation risk if buyback program continues at elevated prices or accelerates before stock recovers
Long-term target uplift ($2B→$3B revenue, EBITDA 40-45%) lacks timeline and depends on unproven Finance/IT module cross-sell adoption — regime-shift risk to execution assumptions
Valuation (P/FCF 14x, P/S 3.87x) appears attractive but still prices in sustained 12%+ FCF growth, which requires macro stability; a stagflation or deleveraging regime could cut that growth rate to 0-5%, compressing multiples simultaneously with earnings

Stanley Druckenmiller — 🟡 watch · 52/100 · medium confidence

PCTY presents a genuinely interesting setup from a Druckenmiller perspective but falls short of a high-conviction, concentrated bet. The forward earnings direction is constructive — Q3 FY26 GAAP EPS of $2.07 (+26% YoY), recurring revenue +14% YoY in Q1 FY26, raised full-year guidance ($1.715-1.730B revenue, $638-642M adj EBITDA), and elevated long-term targets ($3B revenue, 40-45% EBITDA margins). The second derivative on margins is clearly inflecting upward (gross margin up 110 bps, EBITDA margin expansion, FCF margin targeting 25-30%). This is the kind of earnings acceleration that historically rewards macro-momentum positioning. However, three critical Druckenmiller criteria are not cleanly met. First, the tape is deeply problematic: the stock is at its 52-week low ($106.35), sitting 46% below its 52-week high of $197.78 — this is not a leadership stock making new highs; this is a broken chart. Price action is the first thing I check, and this tape is screaming distribution while management is telling me the business is accelerating. That disconnect is a major red flag, not an opportunity to average into. Second, the monetary tailwind is ambiguous. The narrative assumes 25bps rate cuts (Dec, March, April) with ~$110M annual client-fund interest income — this means the business is partially sensitive to rate trajectory, and if Fed easing is slow, the float income tailwind weakens. The broader liquidity cycle is not unambiguously expansive right now. Third, the Finance/IT module expansion is 'early days' with no disclosed pipeline metrics, attach rates, or unit economics — the forward catalyst exists but lacks the precision needed to size a concentrated bet. The DCF shows massive upside ($255 intrinsic vs $106 price) but at 7% WACC with 12% FCF growth, the terminal value is 83% of the valuation — highly sensitive to assumptions and not a clean macro-momentum trade. The $500M buyback at $172/share now looks deeply underwater, signaling potential capital allocation misjudgment. Jefferies cut target to $135 from $150. Revenue growth has decelerated from 20%+ CAGR to guided 8-10% — while the profitability story is improving, the top-line growth rate of change is not accelerating.

Key points

Earnings direction inflecting positively: GAAP EPS +26% YoY Q3 FY26, recurring revenue +14% Q1 FY26, raised full-year guidance — second derivative on profitability is clearly moving up
Long-term target upgrade is significant: $3B revenue target, 40-45% EBITDA margin, 25-30% FCF margin — management is making a credible bull case for compounding
FCF generation is robust: $405M FCF in FY25 (27.5% margin), nearly zero debt (D/E 0.0009), clean balance sheet allows clear earnings trajectory analysis
Valuation has compressed dramatically — 46% off highs — creating potential asymmetry IF the tape confirms, but current price is at 52-week low which is the opposite of tape confirmation
AI adoption (1.2M+ questions, usage doubled YoY) and Finance/IT platform expansion represent identifiable secular catalysts with multi-year runway
DCF intrinsic value $255 vs $106 price implies 140% upside at base case, but 83% terminal value weighting means this is highly assumption-sensitive

Red flags

CRITICAL — tape is broken: stock at 52-week LOW ($106) while 52-week HIGH was $197.78, a 46% drawdown; price action directly contradicts the bullish fundamental narrative — this alone prevents a high-conviction long sizing
Revenue growth decelerating: 3-year CAGR 20% but FY26 guidance implies only 8-10% top-line growth — the top-line second derivative is moving the WRONG direction even as margins improve
$500M in buybacks executed at ~$172/share (Q1 FY25-26) when stock is now $106 — management bought aggressively into what became a major drawdown, raising capital allocation credibility questions
Client-fund interest income (~$110M annually, ~7% of FY26 revenue) is rate-sensitive; if Fed cuts faster than assumed, this non-operating tailwind reverses and hits guidance
Finance/IT module expansion is 'early days' with no disclosed metrics (pipeline, attach rates, win rates) — the catalyst exists but cannot be precisely timed or sized, making it hard to define an invalidation point
Jefferies cut price target $150→$135 post-Q1 despite maintaining Buy — analyst community recalibrating downward, not upward; no positive estimate revision cycle evident
Sector-wide software valuation pressure and rate sensitivity mean the macro tailwind is not unambiguously supportive; unclear Fed easing pace is a headwind for multiple expansion

Howard Marks — 🟡 watch · 52/100 · medium confidence

PCTY sits at an interesting juncture for Marks-style risk analysis: the stock is down ~46% from its 52-week high of $197.78, sitting at $106.35, and the DCF model (using conservative 12% FCF growth, 7% WACC) produces an intrinsic value of ~$255/share — implying substantial upside. However, the Marks framework demands I interrogate what is priced in, whether the margin of safety is real, and whether the sentiment has genuinely cleared to capitulation or merely corrected from euphoria. The balance sheet is nearly debt-free ($938K long-term debt, $162M cash, net cash position of ~$161M) — a genuine structural strength. FCF is real and growing ($405M in FY25, 27.5% margin), ROIC is 21.9%, and operating margins are solid at 20.7%. These are not distressed characteristics. The question is whether the price decline from ~$197 to ~$106 represents true fear-driven dislocation or merely a correction from overvaluation to fair value. The consensus still appears moderately bullish: Jefferies maintains Buy at $135, sentiment is mixed-to-bullish on forums, analyst coverage is active, and multiple sources flag PCTY as a 'GARP candidate.' This is NOT revulsion or forced selling — it is a quality company that got expensive and has corrected to a more reasonable level. The DCF's 83% terminal value dependency (residual_value_pct = 0.833) is a red flag: nearly all the modeled value rests on assumptions about a decade-plus future, where macro, competitive, and AI disruption risks compound. Recent Q3 FY26 results show revenue growth decelerating to ~10.5% YoY vs. prior 14% recurring, with Q4 guided at only 7-8% — a meaningful step-down that challenges the 12% FCF growth assumption baked into the DCF. Management's $3B long-term revenue target lacks a timeline, and Finance/IT modules are anecdotal-stage. Client-fund interest income (~$110M annually) is rate-sensitive and not a durable earnings driver. The sentiment shift is partial, not extreme: retail still skewing bullish, options traders buying calls, and the stock is AT its 52-week low today (current price equals 52-week low per the data), suggesting the pendulum has moved toward caution but not fear. Price-to-FCF of 14x is genuinely undemanding for this quality level, and P/E of 25x is reasonable given the growth profile. But the bar for a Marks-style 'pass' requires either (a) the crowd has fled and left real cheapness, or (b) a demonstrable catalyst for permanent-loss avoidance with asymmetric upside. Neither is conclusively present. The case is intriguing but not yet compelling enough for high conviction.

Key points

Balance sheet is fortress-grade: $938K long-term debt vs. $162M cash; debt-to-equity 0.0009 — zero financial distress risk, which is a prerequisite Marks demands before anything else
Stock has corrected ~46% from 52-week high of $197.78 to $106.35 (at the 52-week low), creating a genuine sentiment reset from prior euphoria — the pendulum has moved toward fear
FCF at $405M, 27.5% margin, and P/FCF of 14x is genuinely undemanding for a business compounding FCF at 20%+ CAGR over 3 years; this is not a price that embeds perfection
DCF intrinsic value of $255/share implies ~140% upside at base case — even the bear scenario at $191.78 implies 80% upside, providing theoretical margin of safety
ROIC of 21.9% and operating margin of 20.7% confirm the business earns well above its cost of capital — durable economics reduce permanent-loss risk
Revenue growth decelerating: Q3 FY26 at 10.5% YoY, Q4 guided 7-8%; DCF assumes 12% FCF growth — this gap is material and the model may be optimistic
83% of DCF value sits in terminal value — highly sensitive to long-run growth and WACC assumptions; not a conservative valuation methodology by Marks standards
Client-fund interest income (~$110M/year) is rate-sensitive and non-operational; a 100 bps rate cut cycle removes a meaningful earnings prop

Red flags

Consensus still moderately bullish (Jefferies Buy at $135, retail sentiment skewing bullish, options traders buying calls) — not the revulsion or forced selling Marks prizes as a contrarian signal
Revenue growth deceleration is real and accelerating downward (Q4 FY26 guided 7-8% vs. 14% in Q1 FY26) — the DCF's 12% FCF growth anchor may be too optimistic, compressing the margin of safety
Finance/IT module traction is anecdotal ('pleased with momentum') with no disclosed metrics on revenue contribution, attach rates, or pipeline — long-term $3B target has no timeline
Terminal value represents 83% of DCF equity value — this structure is highly sensitive to assumptions and does not satisfy Marks' preference for downside-anchored, conservatively verifiable value
Insider selling: CFO sold 1,034 shares (Rule 10b5-1) and SVP sold 70 shares open-market in June 2026, though modest in absolute terms, directionally cautious
Share repurchases at $172.30/share ($200M in Q1 FY26) when stock now trades at $106 — management destroyed ~$40M in buyback value relative to current price, raising capital allocation judgment questions
Software sector faces genuine AI disruption risk per multiple bearish forum voices; AI may commoditize HCM workflows rather than entrench Paylocity's moat

Seth Klarman — 🟡 watch · 48/100 · medium confidence

Paylocity is a high-quality HCM SaaS business with genuine FCF generation, but it does not clear the Klarman margin-of-safety bar as I apply it. The DCF implies $255/share intrinsic value vs. $106.35 current price — a 140% upside that looks compelling on the surface, but that DCF is overwhelmingly terminal-value driven (83% of equity value from the terminal, per the model's own caveat). A Klarman-style appraisal discards or deeply haircuts terminal value and instead anchors to normalized, near-term cash flows and asset backing. On that basis: (1) The balance sheet offers minimal hard-asset backing — stockholders' equity of ~$1.1B against market cap of ~$5.7B; tangible book is likely negative once goodwill/intangibles from the Airbase and other acquisitions are stripped (exact figure not disclosed in filing excerpts but current liabilities of $5.68B vs. current assets of $5.89B, a thin 1.04 current ratio, and $938K long-term debt suggest the balance sheet is operationally healthy but asset-light, not asset-covered). (2) FCF yield at 14x price-to-FCF (~7.1% FCF yield) is not a deep-value entry — it is a fair price for a good compounder, but Klarman's standard demands a real discount to conservative value, not fair value. (3) Revenue growth is decelerating: FY25 was ~15% vs. 3-year CAGR of ~20%, and Q3 FY26 came in at 10.5% YoY — the earnings call narrative projects FY26 total revenue of $1.715–1.730B, implying ~17% growth over FY25 full-year, but Q4 guidance of 7-8% growth signals deceleration. Any further step-down compresses the DCF dramatically. (4) The intrinsic value case rests primarily on the terminal value and on sustained 12%+ FCF growth — exactly the kind of optimistic growth dependency Klarman explicitly rejects. Stress-test: at 6% FCF growth and a 9% WACC (more conservative), the per-share value shrinks materially. (5) Long-term targets ($3B revenue, 40-45% EBITDA margin) lack phasing and rely on Finance/IT modules that are currently early-stage with no disclosed revenue contribution — these are 'story' elements that Klarman would exclude from base valuation. (6) There is no special-situation catalyst, no forced-seller dynamic, no distress, no complexity arbitrage — this is a well-covered, institutionally owned, NASDAQ-listed growth name. The price decline from $197.78 to $106.35 (46% off highs) is notable and could reflect some technical/sentiment overshoot, but the business is not orphaned or misunderstood. (7) Positives: near-zero long-term debt ($938K), strong FCF ($405M, 27.5% margin), rising profitability, disciplined buybacks, and a legitimate moat in SMB/mid-market HCM. These prevent an 'avoid' verdict. The FCF yield and decelerated growth open a small window of interest at current prices. But Klarman would demand a larger discount, clearer asset backing, and a catalyst before committing. The right posture is 'watch' — monitor for further price weakness (sub-$90 would open a more compelling FCF yield of ~9%+ and a larger explicit margin of safety) or a dislocation event.

Key points

FCF of $405M and 27.5% FCF margin is real and growing; price-to-FCF of 14x (7.1% yield) is the most defensible valuation anchor
Virtually zero long-term debt ($938K) and strong operating cash flow provide balance sheet safety, even if tangible asset backing is thin
Revenue growth decelerating from 20%+ CAGR to 10.5% in Q3 FY26 — terminal-value-dependent DCF is sensitive to this
DCF intrinsic value of $255 is 83% driven by terminal value — Klarman would heavily discount this and anchor to near-term normalized cash flow
46% decline from 52-week high creates some dislocation but not a forced-seller or orphaned-security dynamic
Finance/IT platform expansion and embedded retirement plans are real optionality but unquantified — excluded from conservative base case
Share repurchases ($500M cumulative) at higher prices ($172/share) raise capital allocation questions; ongoing $500M authorization at current prices is more constructive

Red flags

No genuine margin of safety at current price vs. a conservative (non-terminal-value) intrinsic value estimate
Value thesis depends heavily on sustained 12%+ FCF growth and terminal assumptions — classic optimism dependency Klarman rejects
Thin tangible asset backing: price-to-book of 5.2x; goodwill/intangibles likely dominate book value; no liquidation-floor support
No special situation, forced seller, or catalyst to close any valuation gap — well-covered institutional name
Revenue growth deceleration (20% CAGR → 10.5% latest quarter) increases DCF sensitivity and compresses the bull case
Client-fund interest income (~$110M annually) is a rate-sensitive non-operating tailwind that reverses with rate cuts — overstates normalized FCF
Early-stage Finance/IT modules cited in management targets are unverified story elements with no disclosed revenue or win-rate data

Benjamin Graham — 🔴 avoid · 28/100 · high confidence

Paylocity is a profitable, growing business with genuine earnings power, but it fails nearly every Graham quantitative test for value investing. The stock trades at 25x trailing earnings, 5.2x book, and 3.9x sales — all far above Graham's conservative thresholds. The balance sheet is structurally weak for value purposes: current ratio is only 1.04 (well below Graham's 2.0 minimum), current liabilities of $5.68B dwarf working capital, and total liabilities of $5.87B are 5.3x stockholders' equity of $1.10B. While long-term debt is negligible ($938K), the massive current liabilities — primarily client-fund obligations held as a payroll processor — create an optically distorted balance sheet. Even netting out client funds, the balance sheet does not meet Graham's conservative standards. The DCF intrinsic value of $255 per share implies 140% upside, but this is a forward-looking, growth-dependent estimate relying on 12% FCF growth and a 7% WACC; Graham would reject such assumptions as speculative. His conservative intrinsic value method — capitalizing demonstrated earnings at 15x — yields roughly $106 per share (EPS ~$4.12 at current P/E implied earnings), suggesting no margin of safety whatsoever at today's price. No dividend is paid. The P/E x P/B test (25x × 5.2x = 130) obliterates Graham's 22.5 threshold by nearly 6x. The only positives are genuine earnings stability (profitable every year reviewed), strong FCF generation (27.5% margin), low beta (0.52), and negligible long-term debt. Revenue has compounded at 20% over 3 years, but Graham explicitly did not pay for growth — he required a price that worked even if growth disappointed. At $106, investors are paying a full price for a high-quality HCM platform, not a Graham-style bargain.

Key points

Trailing P/E of 25x vs. Graham defensive ceiling of 15x — no margin of safety on earnings
P/E × P/B = 25 × 5.18 = 129.5, vs. Graham's 22.5 maximum — fails by 5.7x
Current ratio of 1.04 fails Graham's minimum of 2.0 by a wide margin
No dividend paid — fails Graham's dividend reliability criterion
Earnings are positive and growing (10-year look-back shows consistent profitability) — this is the primary passing criterion
Long-term debt is negligible ($938K), which is a genuine positive
FCF margin of 27.5% and ROIC of 21.9% reflect a quality business — but quality does not equal value at any price
DCF intrinsic value of $255 is growth-dependent and speculative by Graham standards; he would not use it

Red flags

Price at 52-week high ($106.35) — Mr. Market is not pessimistic; no opportunity to buy from fear
P/B of 5.18x — price far exceeds net asset value; net-net analysis shows deeply negative NCAV
Current liabilities ($5.68B) nearly 100x stockholders' equity — structurally leveraged balance sheet regardless of client-fund explanation
No margin of safety: earnings-yield-based intrinsic value roughly equals current price with no buffer for error
Zero dividend history — no shareholder discipline signal that Graham required
Lofty valuation multiples priced for continued 12%+ growth; any slowdown destroys the investment case
Stock at 52-week high, not a pessimistic market — Graham required buying from Mr. Market's despair, not his optimism

Walter Schloss — 🔴 avoid · 18/100 · high confidence

Paylocity is a high-quality, asset-light SaaS/HCM software business that scores very poorly against every Schloss criterion. Price-to-book is 5.18x — far above tangible book, and tangible book is further reduced by goodwill and intangibles on an asset-light balance sheet. The stock is trading at its 52-week HIGH ($106.35 = 52w high), the exact opposite of the beaten-down, out-of-favor bargain Schloss sought. While long-term debt is negligible ($938K), the balance sheet is dominated by intangible/software assets, client-fund liabilities ($5.87B total liabilities vs $6.97B assets), and deferred revenue — not tangible hard assets like plant, real estate, or working capital that can be independently appraised. Stockholders' equity of $1.098B is modest relative to $5.69B market cap. There is no dividend. Insiders are selling (CFO sold 1,034 shares under 10b5-1; SVP sold 70 shares open-market). The thesis is entirely dependent on SaaS growth narratives, AI adoption, new product modules (Finance, IT), and earnings forecasts — precisely what Schloss avoided. The DCF intrinsic value of $255/share sounds attractive but rests on 12% FCF growth and a terminal value that comprises 83% of equity value — pure forecast dependence. Net tangible assets are not a meaningful floor here; the business value lives in customer relationships, software, and recurring revenue, none of which are hard assets Schloss could appraise conservatively. This is a fine business but an anti-Schloss investment in every dimension.

Key points

Price-to-book of 5.18x — rich by any Schloss standard; no discount to tangible assets
Stock at its 52-week HIGH ($106.35), the opposite of a beaten-down Schloss bargain
Negligible long-term debt ($938K) is the one positive, but balance sheet is asset-light not asset-rich
$5.87B in total liabilities dominated by client-fund obligations, not funded by hard collateral
No dividend paid; no visible insider buying; CFO and SVP selling shares
Entire valuation thesis rests on SaaS growth, AI adoption, and product expansion — not verifiable hard assets
83% of DCF equity value is terminal value — extreme dependence on long-range forecasts
Operating history is clear from filings but business model complexity (client-fund float, SBC, multi-product) is not Schloss-simple

Red flags

Trading at 52-week high — Schloss never bought strength, only deep disfavor
P/B of 5.18x with no tangible asset floor to protect downside
Insiders selling (CFO 10b5-1 plan, SVP open-market sale) — not aligned buying
Thesis is 100% growth-narrative dependent: Finance/IT modules, AI assistant, long-term targets to $3B revenue
No dividend despite strong FCF — cash returned via buybacks at rich multiples, not income to patient holders
Asset-light software model: no plant, real estate, or inventory that Schloss could appraise as downside protection
SBC remains meaningful (targeting 5% of revenue = ~$73M/year at current scale) — ongoing dilution risk

Fact base appendix

Price

last_close: 106.35
as_of: 2026-06-28
high_52w: 106.35
low_52w: 106.35
pct_below_52w_high: 0.0

Fundamentals

last_price: 106.35
market_cap: 5694410945
fifty_two_week_high: 197.78
fifty_two_week_low: 92.99
beta: 0.51831985
currency: USD
exchange: NASDAQ NMS - GLOBAL MARKET
sector: Professional Services
industry: Professional Services
price_source: finnhub
bars: 1
entity: PAYLOCITY HOLDING CORPORATION
fiscal_year: 2025
revenue: 1471801000
revenue_period: 2025-06-30
net_income: 227127000
net_income_period: 2025-06-30
operating_income: 304024000
operating_income_period: 2025-06-30
operating_cash_flow: 418226000
operating_cash_flow_period: 2025-06-30
capex: 13073000
capex_period: 2025-06-30
total_assets: 6972784000
total_assets_period: 2025-12-31
total_liabilities: 5874469000
total_liabilities_period: 2025-12-31
current_assets: 5893928000
current_assets_period: 2025-12-31
current_liabilities: 5678054000
current_liabilities_period: 2025-12-31
stockholders_equity: 1098315000
stockholders_equity_period: 2025-12-31
cash_and_equivalents: 162495000
cash_and_equivalents_period: 2025-12-31
long_term_debt: 938000
long_term_debt_period: 2013-06-30
shares_outstanding: 55161627
operating_margin: 0.2066
net_margin: 0.1543
roe: 0.2068
debt_to_equity: 0.0009
current_ratio: 1.038
roic: 0.2185
free_cash_flow: 405153000
fcf_margin: 0.2753
pe_ratio: 25.07
price_to_fcf: 14.05
price_to_sales: 3.87
revenue_cagr: 0.2019
revenue_cagr_years: 3
fundamentals_source: edgar_companyfacts
price_to_book: 5.18
earnings_yield: 0.0549
peg: 1.24

Filings reviewed

10-Q (2026-05-08) https://www.sec.gov/Archives/edgar/data/1591698/000159169826000037/pcty-20260331.htm
8-K (2026-05-07) https://www.sec.gov/Archives/edgar/data/1591698/000159169826000036/pcty-20260507.htm
10-Q (2026-02-06) https://www.sec.gov/Archives/edgar/data/1591698/000159169826000007/pcty-20251231.htm
8-K (2026-02-05) https://www.sec.gov/Archives/edgar/data/1591698/000159169826000005/pcty-20260205.htm
10-K (2025-08-06) https://www.sec.gov/Archives/edgar/data/1591698/000159169825000087/pcty-20250630.htm
10-K (2024-08-02) https://www.sec.gov/Archives/edgar/data/1591698/000159169824000151/pcty-20240630.htm

Other sources

[news] Paylocity Holding Corp (PCTY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
[news] Paylocity Holding Corp (PCTY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
[news] Paylocity Holding Corp (NASDAQ:PCTY) Stands Out in Affordable Growth Screen - ChartMill
[news] Paylocity (PCTY) CFO sells 1,034 shares under pre-set Rule 10b5-1 plan - Stock Titan
[news] Paylocity Holding Corp (PCTY) Shares Fall 4.3% -- What GF Score of 76 Tells Investors - GuruFocus
[news] Is Paylocity Holding Corp (PCTY) a Bargain After 3.2% Drop? GF V - GuruFocus
[news] Paylocity Holding Corp. Actuals & Estimates (NASDAQ:PCTY) - TradingView
[news] Price to earnings forward of Paylocity Holding Corp. – LSX:A1XE9W - TradingView
[news] Is Paylocity (PCTY) Using Embedded Retirement Plans to Deepen Its HCM Moat? - Sahm
[news] Paylocity Holding Corp (NASDAQ:PCTY): A Strong GARP Candidate for Affordable Growth Investors - ChartMill
[news] How to Invest in Paylocity Holding Corp (PCTY) - The Motley Fool
[news] [144] Paylocity Holding Corp SEC Filing - Stock Titan
[news] 0P7 Forecast — Price Target — Prediction for 2027 - TradingView
[news] Paylocity Holding (PCTY) Stock Could Be 33.9% Undervalued After Retirement Plan Launch - Sahm
[news] Paylocity (PCTY) SVP logs small 70-share open-market stock sale - Stock Titan
[discussion] Anvesti opened a long position $PCTY · Entry $103.72 Model: ml_model_v3 · Score: 77.2
[discussion] $PCTY Share Price: $101.13

Contract Selected: Nov 20, 2026 $100 Calls

Buy Zone: $16.41 – $20.27 Ta

[discussion] [Bullish] $PCTY oversold again!
[discussion] [Bullish] $PCTY
[discussion] [Bullish] $PCTY 👀
[discussion] $PCTY Regional banks and payments processing companies report strong Q1 2026 earnings driven by net
[discussion] $PAYC $FRSH $HUBS $PCTY $MNDY ... so many others https://stocktwits.com/news-articles/markets/equit
[discussion] [Bullish] $PCTY under $100 is gold loading zone! Look at those financials!
[discussion] $PCTY Paylocity price target lowered to $135 from $150 at Jefferies

Jefferies lowered the firm&#3

[discussion] Paylocity Q3 Earnings Call Highlights $PCTY #Paylocity #instantalerts #NASDAQ:PCTY https://www.marke
[discussion] $MNST $TXRH $RKLB $MCHP $PCTY

AFTER-HOURS MOVERS:

Currently Higher After Earnings:

Akamai
[discussion] $PCTY Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $2.07 up 26.22% YoY • Reported

[discussion] [Bearish] Ai Trade Update May 05:

Last and final update! Thanks to everyone!

Ai Losers. Prot

[discussion] [Bullish] $LAW The addition of Toby Williams, a top notch CEO with a massive experience in high grow
[discussion] [Bearish] Ai Trade Update April 23

Ai erodes software margins...so sad.

List of Ai Losers. Pr

[earnings_call] Paylocity Holding Corporation PCTY Q1 2026 Earnings Call

Generated 2026-07-17T20:35:12 · est. cost $1.49

What each investor thinks

Philip Fisher Growth

pass · 82

Chuck Akre Quality

pass · 78

Valuation Referee (Damodaran-style) Referee

pass · 78

Terry Smith (Fundsmith) Quality

pass · 78

Michael Mauboussin Quality

pass · 76

Probabilistic Distribution:

Bull case (25% weight): Finance and IT modules gain traction, recurring revenue sustains 12–15% growth, EBITDA margins reach 40%+, FCF compounds at management's long-term targets. Intrinsic value $200–255. Significant upside.
Base case (50% weight): Core HCM growth moderates to 8–10%; Finance/IT contribute incrementally but not transformatively; margins expand modestly. FCF grows 8–10% annually. Intrinsic value $140–190. Material upside from current price.
Bear case (25% weight): SMB/mid-market softness, faster rate cuts hammer client-fund interest income (~$110M annually, ~27% of operating income), AI investment proves dilutive, sector re-rating compresses multiples. FCF growth stalls at 4–5%. Intrinsic value $90–120. Limited downside from current levels but de minimis upside.

What I Need to Change My Mind (Even More Bullish): Finance and IT module revenue disclosed and growing 25%+; gross retention above 92% confirmed; EBITDA margin trajectory toward 42%+ in FY27.

Charlie Munger Quality

pass · 74

Forensic Short-Seller (Chanos/Einhorn-style) Referee

pass · 72

AI & Disruption Referee (Christensen-style) Referee

pass · 72

Warren Buffett Quality

watch · 62

Joel Greenblatt Value

watch · 58

Bruce Greenwald Value

watch · 58

Peter Lynch Growth

watch · 58

Ray Dalio Risk

watch · 52

Stanley Druckenmiller Risk

watch · 52

Howard Marks Risk

watch · 52

Seth Klarman Value

watch · 48

Benjamin Graham Value

avoid · 28

Walter Schloss Value

avoid · 18

Want this on a name you own?Send a ticker; we convene the full council on it.

Request Analysis →